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ABSTRACT 
 
 
Singh, Amanpreet. Ph.D., Biomedical Sciences Ph.D. Program, Wright State University, 
2016. Novel Cell Killing Mechanism of Hydroxyurea in the Fission Yeast 
Schizosaccharomyces pombe and Its Implications in Improving Antifungal Therapy. 
  
 
Hydroxyurea (HU, also known as hydroxycarbamide) is a well known ribonucleotide 
reductase (RNR) inhibitor that depletes cellular deoxyribonucleoside triphosphates 
(dNTPs, the building blocks of DNA). Depleted dNTP pools inside the proliferating cells 
stalls ongoing DNA replication forks, leading to the activation of the well-conserved 
DNA replication checkpoint (also known as intra-S phase checkpoint) pathway. One of 
the major functions of the checkpoint pathway is to protect ongoing forks from 
collapsing. Stalled forks, if not protected by the checkpoint pathway, lead to DNA 
damage and ultimately cell death. Thus it is believed that DNA damage resulting from 
collapsed forks is the underlying cause of cell death induced by HU, although HU may 
kill the cells by other mechanisms. This dissertation focuses on defining a novel cell 
killing mechanism of HU in the fission yeast Schizosaccharomyces pombe.  A mutation 
has been identified in hem13+ encoding coproporphyrinogen III oxidase, an essential 
enzyme involved in the heme biosynthetic pathway that significantly sensitizes the cells 
to HU. We found that the HU sensitivity of the hem13 mutant is a consequence of 
increased production of reactive oxygen species caused by HU treatment, not the 
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DNA damage generated by fork collapsing. This newly identified cell killing mechanism 
of HU in hem13 mutant has great implications in antifungal therapy. 
The first part of this dissertation focuses on the discovery of the novel hem13 mutant in S. 
pombe using genetic screening. The second part rules out the possibility of a checkpoint 
defect in the screened mutant. The third part describes oxidative stress as the novel cell 
killing mechanism of HU in hem13 mutant. In the last part, we show the strong 
synergistic cell killing effect of sampangine (SMP), an inhibitor of heme synthesis and 
HU in S. pombe, S. cerevisiae and the pathogenic fungus Candida albicans.  
Taken together, this dissertation defines a novel cell killing mechanism of HU in S. 
pombe and the synergistic effect of HU and SMP in suppressing cell growth of wild type 
S. pombe, S. cerevisiae and pathogenic fungus C. albicans.
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INTRODUCTION 
DNA replication in eukaryotes 
One of the most challenging and highly regulated processes occurring inside living cells 
is DNA replication. DNA replication is challenging because the replisome has to deal 
with many obstacles such as chromatin packaging, specialized DNA structures, 
transcription machinery and damaged DNA. Tight regulation is required to ensure that all 
chromosomes are replicated only once per cell cycle. Under or over replication of the 
genome can have deleterious consequences for the cell and lead to a number of genetic 
diseases in humans including cancer, birth defects and many developmental 
abnormalities (1).  
 
Initiation of DNA replication in mammals 
DNA replication proceeds with a process called unwinding or melting that causes the two 
strands to separate. Strand separation allows DNA polymerases to copy DNA by 
synthesis of new DNA chains on both strands. The unwinding process begins at multiple 
specific sites along the chromosomes in all eukaryotes. These specific sites are termed as 
the replication origins. The DNA replication origins are bound by multi-protein complex 
including the Origin Recognition Complex (ORC) and two additional proteins, Cdc6 and 
Cdt1 (2). This multi-protein complex aids in the recruitment of the replicative helicase, 
the Mcm2-7 complex and this recruitment process requires ATP. This step is referred to 
as the licensing or pre-replication complex (pre-RC) formation. Mcm2-7 complex is  
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loaded on DNA as a head-to-head double hexamer (3,4). In metazoans, this pre-RC 
formation is blocked by geminin protein, which interferes with the activity of Cdt1 (5,6). 
A Mcm2-7- related protein, Mcm8, has also been implicated in pre-RC formation in 
Xenopus (7). 
The loading of Cdc45 and the GINS complex, onto the pre-RC marks the formation of 
pre-initaition complex (pre-IC). The assembly of these factors requires the activity of 
Cyclin-Dependent Kinases (CDK). CDK inhibitors such as p21 or p27 can specifically 
inhibit this step. Phosphorylation activity of Cdk is required to activate key components 
of pre-IC. One of the components of pre-IC complex, Cdc45, is required for the 
recruitment of DNA polymerases α and δ at the replication origins (8-10). Mcm2-7 
complex has been shown to physically interact with Cdc45 and GINS complex (11). The 
resulting CMG complex is believed to be the active form of the replicative helicase.  It 
has been shown that the Cdc7 protein kinase in complex with Dbf4 (its regulatory 
subunit) phosphorylates Mcm2-7 complex subunits, thereby resulting in a conformational 
change in the helicase complex (12,13). Phosphorylation of two additional proteins Sld2 
and Sld3 by DDK is also required in the formation of pre-IC complex (14,15). This 
phosphorylation is involved in regulating complex formation between Dpb11, Sld2, Sld3, 
GINS and DNA polymerase ε (14-16). Thus, pre-IC complex formation marks the 
loading of active CMG helicase complex and additional components required for DNA 
replication.  
Once the helicase is activated, it begins unwinding of DNA. The unwinding process 
generates stretches of single-stranded DNA (ss-DNA) bound by the replication protein A 
(RPA). The RPA binding stimulates the DNA polymerase activity onto ss-DNA (10,17). 
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Unwinding of DNA by Mcm2-7 helicase also generates topological stress in front of the 
fork. Topoisomerases, the specialized enzymes that can cleave and reseal DNA, reduces 
this stress.  RPA coated ss-DNA is now able to recruit DNA polymerase α/primase. This 
polymerase is unique in that it can initiate DNA synthesis in the absence of 3’ hydroxyl 
end. The enzyme has primase activity that is capable of synthesizing short ribonucleotide 
chains, which can further be extended by catalytic subunit of the enzyme. Later 
polymerase δ takes over whose processivity is very high due to the associated 
proliferating cell nuclear antigen (PCNA) clamp with it that strongly stimulates its 
polymerase activity. PCNA comprises of a homotrimeric ring that is loaded onto DNA by 
its specific loader RF-C complex. The specific loader aids in the opening of the PCNA 
ring in an ATP dependent manner and loads it around the DNA (18). In yeast, a third 
DNA polymerase pol ε has been identified which functions to replicate the leading 
strand. Thus formation of the initiation complex leads to the loading of the replicative 
polymerases.  
 
Elongation and Termination 
Once the replicative polymerases are loaded, the replisome is formed. Bidirectional 
replication proceeds, that is two replisomes originating from an origin of replication. This 
basic structure is referred to as replicon (19). Apart from the basic replication machinery, 
additional factors such as Fen1, DNA ligase are required in the maturation and sealing of 
DNA strands (18). The replisome originating from different replicon will encounter each 
other, once the replicons have been completely replicated. It is believed that this leads to 
the unloading of replisome from the chromatin, possibly by collision of the two  
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Figure 1. Schematic model depicting activation of DNA synthesis in mammals (20).
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replisomes. 
 
Regulation of DNA synthesis by CDKs and DDK in mammals    
Progression into S phase requires the kinase activity of CDK. Its binding partner, a 
cyclin, regulates CDK activity. CDK2 in complex with Cyclin E is important for G1 to S 
phase transition and CDK2/Cyclin A complex is required for progression through S 
phase. The phosphorylation of specific residues of Cyclin/CDK complex keeps it in 
inactive state. This phosphorylation is removed by CDC25 family of phosphatases, which 
results in the activation of the complex (21). CDC25A dephosphorylates threonine 14 and 
tyrosine 15 within the ATP binding loop on CDK1 and CDK2. Thus DNA synthesis is 
driven by CDK activity, which is highly regulated. 
 
G1 to S phase transition 
In mammals, G1 to S phase transition requires the activity of CDK2/Cyclin E and CDK4 
/Cyclin D1. The CDK4/Cyclin D1 protein complexes are specifically required for S-
phase specific transcriptonal program, while CDK2/Cyclin E is important for the 
activation of pre-IC complex. Sld2 and Sld3 are phosphorylated by CDK2/Cyclin E 
(14,15) complex and this event facilitates protein-protein interaction and the activation of 
the Mcm2-7 complex. Low CDK activity is required during pre-RC assembly and G2 
phase. A premature activation of CDK during pre-RC assembly can lead to inhibition of 
origin licensing or re-replication in G2 phase (22). Most of the key players involved in 
DNA replication and its regulation are conserved from yeasts to humans. 
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Replication stress and checkpoint activation 
Considering the importance of DNA replication in cell cycle, the progression of DNA 
replication is very carefully monitored inside the cells. The stability of the genome 
depends upon the precise operation of the DNA replication machinery and the DNA 
replication checkpoint pathway. 
 
Replication stress generated by hydroxyurea (HU) 
HU, an inhibitor of ribonucleotide reductase (RNR), has been of clinical and scientific 
interest for more than 100 years (23). Diverse biological activities, which include 
antibacterial, antifungal, antitumor and anti-inflammatory effects, have been 
characterized for HU (23,24). It has also been used to treat sickle cell anemia, leukemia 
and other malignancies, psoriasis and thrombocythemia. One major reason that this 
molecule has been well studied is because of its effect on its primary target, RNR (25). 
RNR is required for furnishing the precursors of DNA synthesis by catalyzing the 
reduction of ribonucleoside diphosphates to deoxyribonucleoside diphosphates (26). In 
eukaryotes, RNR is composed of two large and two small subunits that form a hetero-
tetrameric enzyme. The larger subunits have both catalytic and allosteric sites and the 
small subunit contains an oxo di-ferric iron center that aids in the formation of a 
catalytically essential tyrosyl free radical (26). Because RNR is an essential enzyme 
involved in the synthesis and repair of DNA, there has been extensive research to find 
small molecule inhibitors of the enzyme that can be used to treat cancers. For example, 
inhibitors have been developed involving the iron chelators that can inhibit the formation 
of the oxo di-ferric iron center in the small subunit (27). Inhibitors of another class called 
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radical scavengers have been developed as well, which have the ability to quench the 
tyrosyl free radical of the small subunit (26). HU is an example of this class. It can 
specifically inhibit RNR because overexpression or mutation of the small subunit of RNR 
has been shown to confer increased resistance to HU (25).  
HU treatment leads to dNTP depletion inside the cells thereby generating replication 
stress, leading to the activation of ATR (ATM-and Rad3-related) mediated checkpoint 
signaling pathway (28) in mammals. Activated ATR phosphorylates various substrates to 
maintain genomic integrity.   
 
Activation of the DNA replication checkpoint pathway in fission yeast S. pombe 
The replication checkpoint pathway can be functionally separated into three conceptual 
parts, sensors, mediators and effectors. (29-31). In S. pombe, the key component of the 
DNA replication checkpoint pathway (Fig. 2) is the effector kinase Cds1 (CHK2 in 
humans) (32-34). Some of the direct targets of Cds1, such as Mus81 (35), Rad60 (36) and 
Wee1, are specialized for dealing with S phase perturbations (37). Once activated by the 
sensor kinase Rad3 (ATR in humans), Cds1 mediates most of the protective responses 
inside the cells. Although the activation mechanism of Cds1 (Fig. 3) is relatively clear 
(33,38,39), the activation of Rad3 is poorly understood. Most of the in vitro studies in 
other model organisms (40-43) suggest that dNTP depletion inside the cells leads to 
transient uncoupling of the replicative helicase and polymerase at the perturbed forks 
generating ss-DNA coated by RPA. Rad3 recognizes this RPA coated ss-DNA in 
association with its cofactor Rad26 (ATRIP in humans). Another protein complex 
comprising Rad9-Rad1-Hus1 or the “9-1-1” checkpoint clamp complex is loaded by its 
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loader Rad17-Rfc2-5 complex onto the junctions of single to double stranded DNA in 
close proximity to the Rad3-Rad26 complex (44,45). Once these complexes are loaded, 
Rad3 is activated by a poorly understood mechanism. Activated Rad3 phosphorylates 
Mrc1 (mediator of replication checkpoint) and Rad9 in the “9-1-1” complex. 
Phosphorylated Rad9 can recruit other factors such as the replication initiation protein 
Rad4 (Dpb11 in budding yeast, TopBP1 in humans) to the stalled forks. In S. cerevisiae 
and metazoans, the recruited Dpb11 or TopBP1 has been shown to activate the sensor 
kinase by the “ATR- activation domain” to enhance signaling activity of the checkpoint 
pathway (42,43,46,47). However this result has not been rigorously tested in vivo. Recent 
studies have shown that the kinase activity of Rad3/ Mec1 stays intact in Rad4/Dpb11 
mutant lacking the “ATR activation domain” (48-50), suggesting that activation of the 
sensor kinase in both yeasts may not require Rad4 or Dpb11 under replication stress. 
Alternatively, redundant factors are required to activate the sensor kinase (51-53).  
 
Protective cellular responses induced by activated checkpoint 
Under the conditions of a replicative stress, the DNA replication checkpoint is absolutely 
required for cell survival. Once activated, the pathway elicits a number of protective 
cellular responses, which includes protecting the replisome proteins from disassembling 
at the perturbed forks, increasing the production of deoxyribonucleotides by stimulating 
the RNR (54-56). The activated checkpoint also suppresses the firing of late replication 
origins (57,58) and delays mitosis by controlling the enzymatic activity of CDK (59,60), 
thereby providing ample time for the cells to deal with the stress. All checkpoint 
responses are well coordinated inside the cells to ensure that DNA synthesis can properly 
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Figure 2: Schematic outline of the DNA replication checkpoint in S. pombe 
Recent studies suggest that a common set of sensors is assembled at the stalled forks in 
all eukaryotes for initiation of the checkpoint signaling. In S. pombe, the sensor kinase 
Rad3 phosphorylates and activates the effector kinase Cds1 via the mediator Mrc1. 
Activated Cds1 is responsible for most of the checkpoint functions by phosphorylating 
various downstream targets. The main function of the checkpoint is believed to be the 
stabilization of the stalled forks so that they do not undergo catastrophic collapse.
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Figure 3: Phosphorylation network for efficient activation of Cds1 
The four Rad3-dependent phosphorylations (marked with letter P) occur in parallel. Rad3 
phosphorylates Thr11 in Cds1 at a basal level in the absence of Mrc1, Rad9, or 
phosphorylation of the two proteins. Phosphorylation of the SQ cluster and the TQ motifs 
in Mrc1 and Thr412 in Rad9 can all facilitate the phosphorylation of Cds1-Thr11 by Rad3. 
Although phosphorylation of Mrc1 TQ motifs recruits Cds1 for its phosphorylation at 
Thr11 by Rad3, it remains unclear how phosphorylated Mrc1 SQ cluster and Rad9-Thr412 
promote phosphorylation of Cds1-Thr11 (dashed arrows). Phosphorylation of Thr11 is 
known to promote trans-autophosphorylation of Thr328 in the kinase domain of Cds1, 
which directly activates the enzyme, leading to full activation of the replication 
checkpoint pathway in S. pombe.
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resume once the stress subsides. Consistent with the importance of the pathway in 
protecting the genome integrity and cell survival, the pathway is highly conserved from 
yeast to humans and defects in the pathway predispose to cancer (61-63). 
 
Cellular responses to various other stresses  
Cells experience a variety of other stress conditions due to damage of the cellular 
structures caused by both exogenous sources such as UV radiation and endogenous 
sources such as reactive oxygen species (ROS) generated from mitochondrial electron 
transport chain. As a result eukaryotes have evolved a variety of cellular stress responses 
that protect the cells from these stress conditions such as the heat shock response and 
oxidative stress response. Failure in the protective responses may result in cell death (64). 
These cellular responses are summarized below. 
	
Heat shock response 
One of the well-characterized and main survival responses initiated by the cells is the 
heat shock response. It is the response initiated by the cells as a result of elevation in 
temperature (65). Heat shock generates protein damage that leads to misfolding of 
proteins. The response aids in thermotolerance, refolding misfolded proteins and prevents 
protein aggregation. The response results in higher resistance of cells to various stress 
conditions such as elevated temperature, anticancer drugs and oxidative stress (66,67). 
General transcription and translation occurring inside the cells is halted, however, the 
transcription of genes required for protective response is enhanced. The cells specifically 
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up regulate genes encoding heat shock factors (HSFs) (68) to protect the cells from stress. 
If the cells cannot cope with the stress, they may follow the fate of death. 
 
Cellular response to unfolded proteins 
Most of the newly synthesized proteins undergo a variety of posttranslational 
modifications in the endoplasmic reticulum (ER).  Various stress conditions such as 
calcium ion imbalance, glucose starvation, increase in temperature and inhibition of 
glycosylation lead to accumulation of unfolded proteins and activation of the unfolded 
protein stress response (69,70). The stress response pathway improves the protein loading 
and folding capacity of endoplasmic reticulum is also enhanced, thereby helping the cells 
to cope with the stress and preventing it from undergoing cell death. 
 
DNA damage response 
Exposure of cells to chemotherapeutic agents, irradiation or environmental genotoxic 
agents such as UV or polycyclic hydrocarbons can generate DNA damage inside the 
cells. Damage to the DNA template leads to the activation of DNA damage response 
(DDR) pathway comprising ATR and ATM (Ataxia Telangiectasia Mutated) kinases. 
Activated kinases phosphorylate various downstream targets (71), to promote the DNA 
repair processes. However if the damage is difficult for the cell to repair, the signal is 
transmitted to induce cell death by apoptosis (72). Apoptosis-like cell death has been 
reported in both S. pombe and S. cerevisiae following DNA damage and replication 
stress, similar to the scenario in metazoa (73). 
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Oxidative stress response 
Aerobically respiring organism generate ROS. Most of them are generated by leakage 
from mitochondrial electron transport chain (74). ROS include superoxide anion (O2−), 
hydrogen peroxide (H2O2) and hydroxyl radical (OH). Under normal conditions, there 
exist a balance between pro-oxidant species and antioxidant defense system. Oxidative 
stress occurs when there is disturbance in this balance. Although cells have both 
enzymatic and non enzymatic defenses that deal with oxidative stress (74), imbalance can 
result in cell death by either apoptosis or necrosis (75,76). Oxidative stress leading to cell 
death by apoptosis has been shown in yeast (77). 
 
Cell death mechanisms in eukaryotes 
Eukaryotic cells are remarkable in that they respond to different stress conditions in a 
variety of ways to promote their survival. The initial response of the cells is to protect 
and recover from the stress. These responses such as DNA damage response and heat 
shock response are conserved in evolution from lower organisms to mammals. However, 
if the stress remains unresolved, the cells follow the fate of death. Various cell deaths 
programs such as apoptosis, necrosis and autophagy are activated that eliminate these 
damaged cells from the organisms. In unicellular organisms such as yeast, some of these 
cell death pathways are also conserved (73). 
 
Apoptosis 
One of the best-characterized cell death mechanisms is apoptosis. It is highly conserved 
throughout evolution (78). Cells exhibit a particular morphology during apoptosis. Cell 
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blebbing, shrinkage, rounding and fragmentation of nuclei, margination of chromatin and 
phagocytosis of cell fragments are all associated with apoptosis (79). Oxidative stress, 
irradiation and chemotherapeutic agents can all trigger apoptosis. The key death effector 
molecules in apoptosis are caspases (80). They belong to a family of cysteine proteases 
that are synthesized in their inactive form and once activated can cleave a variety of 
substrates in the cytoplasm, which eventually lead to the morphological changes 
mentioned above. Caspases can be activated by a number of mechanisms inside the cells. 
One mechanism includes the aggregation of death receptors of tumor necrosis factor 
(TNF) or TNF-related apoptosis inducing ligand (TRAIL), resulting in recruitment of 
Fas-associated death domain (FADD) and procaspase-8 leading to the formation of death 
inducing signaling complex (DISC) (81). Other mechanism of caspase activation 
involves the release of cytochrome c from the mitochondrial intermembrane space (82).  
 
Necrosis 
Necrosis is a mechanism of cell death characterized by loss of control of ionic balance 
resulting in water uptake, swelling and cell lysis (83). Cell lysis results in the release of 
components of the cell, thereby evoking an immune response leading to inflammation. 
The key molecule leading to necrosis mediated cell death is the serine/threonine kinase 
RIP1 (84,85). Reactive oxygen species (ROS) and calcium are also involved in mediating 
necrosis (86). ROS (87) and calcium (88) drive necrosis and have been shown to 
inactivate caspases and apoptotic machinery. 
 
Autophagy   
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Autophagy is an intracellular degradation system that delivers cytoplasmic constituents to 
the lysosome. Sequestration of vesicles, degradation of cytoplasmic proteins and 
organelles are all part of autophagy (89). The resulting double membrane structures are 
called autophagosome. The key genes that regulate autophagosme formation are 
autophagy related genes (atg), which were first identified in yeast (89). Autophagosome 
degrades its contents by acidic lysosomal hydrolases (89). Stresses such as growth factor 
deprivation, inhibition of proteasomal degradation, shortage of nutrients, intracellular 
calcium accumulation and endoplasmic reticulum stress all leads to autophagy (90-92). 
 
Necroptosis 
A programed form of necrosis is referred to as necroptosis. It is a well-defined 
mechanism to defend against viruses, allowing the cells to commit suicide in a caspase 
independent fashion (93). It is specific cell death mechanism employed by vertebrates 
only.  
 
In summary, my dissertation defines a novel cell killing mechanism of HU involving 
oxidative stress in S. pombe and the synergistic effect of HU and SMP in suppressing cell 
growth of wild type S. pombe, S. cerevisiae and pathogenic fungus C. albicans.
	 19	
MATERIALS AND METHODS 
Yeast strains and plasmids  
Standard methods and genetic techniques were used for the yeast cell culture (94). The S. 
pombe strains were usually cultured at 30°C in YES (0.5% yeast extract, 3% dextrose, 
and supplements) or in the synthetic EMMS medium lacking the appropriate supplements 
(94). Glycerol plates were made in YES (0.5% yeast extract, and supplements), in which 
3% glycerol was used to replace 3% dextrose. Yeast strains, plasmids and PCR primers 
used in this study are listed in Table 2, 3 and 4 respectively. All mutations and sequences 
were confirmed by DNA sequencing (Retrogen, San Diego, CA). All yeast 
transformations were carried out by electroporation (Gene Pulser II; Bio-Rad) 
 
Identification of new HU sensitive mutants 
Screening of the new HU sensitive mutants was carried out following a previously 
described method (95). Briefly, the logarithmically growing wild type YJ374 strain was 
harvested and suspended in 50 mM Tris-Maleate buffer, pH 6.0 and treated with 375 
µg/ml methylnitrosoguanidine (MNNG) in the same buffer for 90 min at room 
temperature. MNNG is a potent carcinogen that alkylates genomic DNA at O6 of guanine 
and O4 of thymine, leading to transition mutations between GC and AT. To identify new 
HU sensitive mutants, the mutagenized cells were spread on YE6S plates and incubated 
at 30˚C. The colonies were replica plated onto YE6S or YE6S containing HU to identify 
those that were sensitive to HU. The initially identified HU sensitive mutants were
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backcrossed three times to remove the by-stander mutations. The resulting mutants were 
crossed and compared with known checkpoint mutants in order to identify novel HU 
sensitive mutants.  
 
Disruption of hem13+ gene in wild type diploid strain  
Disruption of hem13+ gene was done by integrating ura4+ marker into a region between 
NcoI [the blunt ends were generated using DNA polymerase I, Large (Klenow) fragment 
(New England BioLabs) for NcoI site] and HincII sites in the open reading frame (196 bp 
to 335 bp from the start codon) in an ura4-D18 diploid wild type YJ18 strain. The 
resulting ura4+ diploid strain was generated. The gene-specific insertion of ura4+ marker 
into the hem13+ gene was confirmed by colony PCRs using primers outside of the 
integration sites. 
 
Integration of Hem13 (T263I) mutation at the genomic locus  
The Hem13 (T263I) mutation was integrated at the genomic locus using the 
∆hem13::ura4+ diploid strain. The wild type and mutant hem13 gene were cloned on 
pIRT-2U vector. Both plasmids containing wild type and mutant gene were cut with 
BspEI and BglII. The resulting 1551 bp fragment was purified by agarose gel 
electrophoresis. The purified fragment was transformed into ∆hem13::ura4+ diploid 
strain. The cells were allowed to recover on YE6S plates for 24 h and replica plated on 5-
fluoroorotic acid (5-FOA) plates to select for ura- colonies. The resulting diploid ura- 
colonies were allowed to sporulate on plates with poor medium. Random spore analysis 
was performed to separate the spores.  
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Drug sensitivity  
To test the drug sensitivity by spot assay, 2 x 107 cells/ml of logarithmically growing S. 
pombe were diluted in five-fold steps and spotted onto YE6S plates containing HU, 
MMS, or CPT at indicated concentrations. The cells spotted on YE6S plates were also 
treated with the indicated doses of UV light (Stratalinker 2400). The plates were 
incubated at 30°C for 3 days and then photographed.  
 
The sensitivity of hem13 cells to acute HU treatment was measured by using a previously 
described method (95). Briefly, HU was added to the liquid culture in YE6S medium at 
the final concentration of 25 mM. At each indicated time point, 10 µl of cells were 
diluted in 10 ml sterile dH2O, vortexed and 100 µl of the cell suspension was then spread 
onto YE6S plates. The plates were incubated at 30°C for 3 days for the cells to recover. 
The number of the colonies resulting from the recovered cells were counted and 
presented as percentages of the untreated cells. Each data point represents an average of 
the colonies from three plates. 
To test the sensitivity of S. pombe to H2O2, 30% w/w aqueous solution of H2O2 (Alfa 
Aesar) was diluted to 3% (880 mM) solution in autoclaved water. Once the YE6S /agar 
solution was cooled enough for pouring, H2O2 was added to the indicated concentrations 
and the YE6S medium containing H2O2 was poured. The plates were kept in dark at 4˚C 
before use. 
 
To assess the cell killing effects of HU, SMP and their various combinations, 
logarithmically growing S. pombe, S. cerevisiae and C. albicans cells were inoculated on 
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96 well plates at 3000 cells/well. Various drugs and their combinations were added to the 
final volume of 200 µl. The same amounts of carriers were added as the control.  Cells 
were incubated at 30˚ C for 48 h.  The plates were scanned in a plate reader at A600.  The 
synergistic, additive, or antagonistic effect of the drug combinations, as indicated by the 
combination index (CI) values for non-constant combo ratios, were calculated by using 
the Chou and Talalay method (96,97).  
 
TABLE 1. Combination Index values  
The table showing the range of the CI values, which were used as reference to determine 
synergism, additive and antagonism for the various drug combinations used.   
Range of 
Combination Index 
 
Interpretation 
<0.1 Synergism (very strong) 
0.1-0.3 Synergism (strong) 
0.3-0.7 Synergism (moderate) 
0.7-0.85 Synergism (slight) 
0.90-1.10 Additive (nearly) 
1.10-1.20 Antagonism (slight) 
1.20-1.45 Antagonism (moderate) 
1.45-3.3 Antagonism 
3.3-10 Antagonism (strong) 
<10 Antagonism (very strong) 
 
Drug combinations used for S. pombe (Fig. 36): 
Conc. of HU used (mM): 0, 1.5, 5.0, 7.5, 10.0 
Conc. of SMP used (mM): 0, 0.004, 0.012, 0.017, 0.021 
Combo 1: (0+0), (1.5+0.004), (5.0+0.004), (7.5+0.004), (10.0+0.004) 
Combo 2: (0+0), (1.5+0.012), (5.0+0.012), (7.5+0.012), (10.0+0.012) 
Combo 3: (0+0), (1.5+0.017), (5.0+0.017), (7.5+0.017), (10.0+0.017) 
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Combo 4: (0+0), (1.5+0.021), (5.0+0.021), (7.5+0.021), (10.0+0.021) 
Drug combinations used for S. cerevisiae (Fig. 39): 
Conc. of HU used (mM): 0, 100.0, 150.0, 200.0, 225.0, 250.0 
Conc. of SMP used (mM): 0, 0.004, 0.008, 0.017, 0.025, 0.034 
Combo 1: (0+0), (100.0+0.004), (100.0+0.008), (100.0+0.017), (100.0+0.025), 
(100.0+0.034) 
Combo 2: (0+0), (150.0+0.004), (150.0+0.008), (150.0+0.017), (150.0+0.025), 
(150.0+0.034) 
Combo 3: (0+0), (200.0+0.004), (200.0+0.008), (200.0+0.017.0), (200.0+0.025), 
(200.0+0.034) 
Combo 4: (0+0), (225.0+0.004), (225+0.008), (225.0+0.017.0), (225.0+0.025), 
(225.0+0.034) 
Combo 5: (0+0), (250.0+0.004), (250.0+0.008), (250.0+0.017.0), (250.0+0.025), 
(250.0+0.034) 
Drug combinations used for C. albicans (Fig. 42): 
Conc. of HU used (mM): 0, 100.0, 150.0, 200 
Conc. of SMP used (mM): 0, 0.064, 0.075, 0.086 
Combo 1: (0+0), (100.0+0.064), (100.0+0.075), (100.0+0.086) 
Combo 2: (0+0), (150.0+0.064), (150.0+0.075), (150.0+0.086) 
Combo 3: (0+0), (200.0+0.064.0), (200.0+0.075), (200.0+0.086) 
 
Sequence alignment 
The protein sequence alignment was done using the following website: 
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http://www.bioinformatics.org/sms2/pairwise_align_protein.html 
 
Generation of anaerobiosis 
Anaerobic environment was generated using Type A Bio-Bag Environmental Chamber 
(Becton Dickinson, BD). To test the drug sensitivity under anaerobic conditions, serial 
dilution of cells were spotted on YE6S alone or YE6S plates containing HU. Type A Bio-
Bag is a transparent, individual, disposable environmental chamber that contains a gas 
generator consisting of one tablet of potassium borohydride and sodium bicarbonate, an 
ampule of hydrochloric acid, a catalyst cup containing palladium catalyst, and an 
indicator containing an ampule of resazurin. The plates and all the components 
mentioned above were put in the Bio-Bag. After the bag was properly heat-sealed, the 
generator was activated. The oxygen reduction indicator, resazurin, was used to monitor 
the oxygen level as per manufacturer’s instructions. 
 
Measuring protein carbonylation levels in S. pombe 
Protein carbonylation was detected by in vitro derivatization of oxidized proteins with 
2,4-dinitrophenylhydrazine (DNPH) (98,99). An overnight culture of yeast cells was 
seeded into fresh medium at 0.1 OD600nm / ml (Optical Density) and incubated at 30˚C for 
about 2 doubling times. The culture was split into 2 tubes, with one exposed to 25 mM 
HU for 4 h and the other to water alone. Similar numbers of cells were harvested and 
resuspended in carbonylation buffer (50 mM Tris-HCl, pH 7.5, 2 mM EDTA, 0.05% NP-
40, 2 mM phenylmethylsulfonyl fluoride (PMSF), 5 mM benzamidine, 0.16 mg/ml 
aprotinin) and lysed using the glass beads method. Cell lysates were centrifuged to 
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eliminate debris. The protein concentration was then determined by Pierce BCA protein 
assay kit (ThermoFisher Scientific). The protein concentration was adjusted to 10 mg/ml 
with the carbonylation buffer. A concentrated 12% solution of sodium dodecyl sulfate 
(SDS) was added to 10 µg of total protein to reach a final concentration of 6%, and 
incubated for 3 min at 100˚C. One volume of 10 mM DNPH in 10% trifluoroacetic acid 
was added to 1 volume of the sample. The reaction was run for 10 min at room 
temperature and stopped by addition of 1 volume of 2 M Trizma base, 10 % glycerol and 
15% 2-mercaptoethanol. Samples were separated by 10% SDS-polyacrylamide gel 
electrophoresis (PAGE) and carbonylated proteins were detected using a polyclonal anti-
2,4-dinitrophenyl (DNP) antibody (Sigma). As a loading control, Protein Kinase G (Pkg) 
was detected using rabbit polyclonal anti-Pkg2 antibody (Sigma). The immunoblotting 
signal was revealed with electrochemiluminescence and photographed by Image Reader 
LAS-3000 (Fuji Film). Intensities of the band were quantitated by ImageGauge (Fuji 
Film). The protein carbonylation level in untreated wild type cells was set as 100%. 
 
Western blotting  
Phospho-specific antibodies against phosphorylated Mrc1-Thr645 and Cds1-Thr11 were 
generated using the chemically synthesized phosphopeptides (33,38). Cds1 was tagged 
with the hemagglutinin (HA) epitope at its C-terminus and immunoprecipitated (IPed) 
from the whole cell lysates made by glass bead method from equal number of cells in the 
buffer containing 50 mM HEPES/NaOH, pH7.6, 1 mM EDTA, 1 mM Na3VO4, 10 mM 
pyrophosphate, 50 mM NaF, 60 mM β-glycerophosphate, 0.1% Nonidet P-40 and 
protease inhibitors. After separation by SDS PAGE, the samples were transferred to a 
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nitrocellulose membrane. The membrane was briefly probed with anti-HA antibody 
(Santa Cruz Biotechnology) to confirm the IP and loading. The immunoblotting signal 
was revealed with electrochemiluminescence and photographed by Image Reader LAS-
3000 (Fuji Film). The same blot was stripped and reprobed with the phospho-specific 
antibody against Cds1-Thr11 for 3 h at room temperature or overnight at 4˚C. 
Phosphorylation of Mrc1-Thr645 was directly examined in whole cell lysates prepared 
from equal number of cells by trichloroacetic acid method (38). The membranes were 
stripped and blotted with polyclonal antibodies against Mrc1 for loading. The Rad3 
dependent phosphorylation of Chk1 was assessed using the mobility-shift method 
developed by Russell lab (100). 
 
Synchronization of cells in G1 phase 
Cdc10 is the transcription factor required for the G1/S transition in S. pombe. Cells 
containing the cdc10-129 temperature sensitive mutation were incubated in YE6S at 
36.5˚C for 4 h. The G1 arrested cells were then released into the cell cycle at a semi- 
permissive temperature of 30˚C, not 25˚C, because of the cold sensitivity associated with 
hem13 mutant. 
 
Flow cytometry 
0.5 OD600nm/ml of logarithmically growing S. pombe cells were collected by 
centrifugation and fixed in 1 ml of ice-cold 70% ethanol for 6 h or overnight at 4˚ C. The 
fixed cells were treated with 0.1 mg/ml RNase A in 50 mM sodium citrate at 37˚ C for 6 
h or overnight and then stained with 4 µg/ml propidium iodide (PI). The stained cells 
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were run through Accuri C6 flow cytometer following standard protocol. The collected 
data was analyzed using software FCS Express 4Flow. FL2-A channel was used for all 
histograms. 
 
Measuring heme levels in S. pombe 
An overnight culture of S. pombe cells was seeded into fresh medium at 0.1 OD600nm / ml 
and incubated at 30˚C for about 6 h.  The culture was split into 3 tubes, with one exposed 
to 25 mM HU for 4 h, one to 0.004 mM SMP for 4 h and the third one treated with 
dimethyl sulfoxide (DMSO) alone as the control. We noted that at 0.004 mM 
concentration, SMP minimally reduced the growth of wild type cells. Similar numbers of 
cells from each culture were collected, washed once with ice-cold water, once with 
phosphate buffer saline and then lysed. 2 µl of each cell lysate was used to measure the 
amount of heme with a hemin assay kit (Bio Vision, CA) according to the manufacturer’s 
instructions. The protein concentration of each cell lysate was also measured by Pierce 
BCA protein assay kit (ThermoFisher Scientific) and used to calculate heme 
concentration as fmol/µg protein. Three independent experiments were performed for 
each culture and the results were averaged. The average heme level in the wild type strain 
TK48 without the drug treatment was set as 100%. 
 
Cloning S. cerevisiae hem13+ and human CPOX genes 
Hem13 from budding yeast and CPOX from humans were cloned from budding yeast and 
human cDNA library respectively and later expressed from S. pombe expression vector 
under the control of nmt (no mRNA in the presence of thiamine) promoter. 
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ROS staining assay 
Logarthmically growing wild type and hem13 cells were treated for 3 h with 25 mM HU 
at 30˚C. After 3 h of incubation in HU, the ROS indicator dye DCFDA (10 µg/ml) was 
added and the cells were cultured for additional 90 minutes. Cells were then harvested 
and washed twice with citrate buffer (50 mM sodium citrate, pH 7.0). The pellets were 
resuspended in citrate buffer with or without PI (4 µg/ml) and then analyzed by flow 
cytometry. The flow data was analyzed using software FCS Express 4Flow. 
 
TABLE 2. List of S. pombe strains used in the study  
Strain Genotype Source 
YJ18 h-/h+ leu1-32/leu1-32 ura4-D18/ ura4-D18 ade-
M210/ade-M216 
T. Kelly Lab  
TK48 h- leu1-32 ura4-D18 ade6-M216 T. Kelly Lab  
NR1826 h- ∆rad3::ura4+ leu1-32 ura4-D18 ade6 P. Russell lab 
GBY191 h+ ∆cds1::ura4+ leu1-32 ura4-D18 ade6-M210 T. Kelly Lab 
YJ15 h+ ∆mrc1::ura4+ leu1-32 ura4-D18 ade6-M210 Y.J. Xu Lab 
LLD3427 h- chk1-9myc-2HA6his::ura4+ leu1-32 ura4-D18 P. Russell lab 
YJ374 h+ cds1-6his2HA(int) leu1-32 ura4-D18 ade6-
M216 
P. Russell lab 
TK197 h+ ∆chk1::ura4+ leu1-32 ura4-D18 ade6-M210 T. Kelly Lab 
TK17 h- cdc10-129 ura4-D18 ade6-M210 Y.J. Xu Lab 
APS18 h+/ h- ∆hem13::ura4+ leu1-32 ura4-D18 ade6 This Study 
APS19  h?hem13(T263I) cds1-6his2HA leu1-32 ade6 This Study 
APS34 h?∆hem13::ura4+ [prom-hem13-term LEU2]ura4-
D18 ade6 
This Study 
APS37 h?∆hem13::ura4+ [prom-hem13 (T263I)-term 
LEU2]ura4-D18 ade6 
This Study 
APS70 h?∆hem13::ura4 leu1-hem13 ade6 This Study 
APS71 h?∆hem13::ura4 leu1-hem13(T263I) ade6 This Study 
APS124 h?hem13(T263I) cds1-6his2HA leu1-32 ura4-D18 
ade6 (int.) 
This Study 
APS187 h?hem13(T263I) cds1-6his2HA [pREP1-H.S. 
hem13-term] ura4-D18 ade6 
This Study 
APS188 h?hem13(T263I) cds1-6his2HA [pREP41-H.S. 
hem13-term] ura4-D18 ade6 
This Study 
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APS189 h?hem13(T263I) cds1-6his2HA [pREP1-S.C. 
hem13-term] ura4-D18 ade6 
This Study 
APS190 h?hem13(T263I) cds1-6his2HA [pREP41-S.C. 
hem13-term] ura4-D18 ade6 
This Study 
APS169 h+ cds1-6his2HA(int) [prom-Suc22-term-LEU2] 
leu1-32 ura4-D18 ade6 
This Study 
APS170 h+ ∆rad3::ura4+ [prom-Suc22-term-LEU2] leu1-32 
ura4-D18 ade6 
This Study 
APS181 h+ ∆cds1::ura4+ [prom-Suc22-term-LEU2] leu1-32 
ura4-D18 ade6 
This Study 
APS183 h? hem13(T263I) cds1-6his2HA [prom-Suc22-term 
-LEU2] leu1-32 ura4-D18 ade6 
This Study 
PEY522 h- ∆sre1::KanR leu1-32 ura4-D18 ade6-M210 
his3-D1 
P. Espenshade 
lab 
FG2341 h? ∆ptc4::ura4+ leu1-32 ura4-D18 ade6 P. Russell lab 
YM526 h? ∆rad3::ura4+ chk1-9myc-2HA6his:ura4+ leu1-
32  
Y.J. Xu Lab 
YM563 h? ∆cds1::ura4+ chk1-9myc-2HA6his:ura4+ leu1-
32 
Y.J. Xu Lab 
APS162 h? cdc10-129 cds1-6his2HA(int) ura4-D18 ade6 This Study 
APS185 h? cdc10-129 hem13(T263I) cds1-6his2HA(int) 
ura4-D18 ade6 
This Study 
APS123 h? ∆rad3::ura4+ hem13(T263I) ura4-D18 ade6 This Study 
APS121 h? ∆cds1::ura4+ hem13(T263I) ura4-D18 ade6 This Study 
APS122 h? ∆chk1::ura4+ hem13(T263I) ura4-D18 ade6 This Study 
APS97 h? hem13-HA:ura4+ leu1-32 ade6 This Study 
APS99 h? hem13(T263I)-HA:ura4+ leu1-32 ade6 This Study 
APS184 h+  ∆rad3::ura4+ [prom-Erg11-term-LEU2] leu1-
32 ura4-D18 ade6 
This Study 
APS171 h? hem13(T263I) cds1-6his2HA [prom-Erg11-
term-LEU2] leu1-32 ura4-D18 ade6 
This Study 
YJ1259 h+ erg11(G189D):ura4+ cds1-6his2HA leu1-32 
ura4-D18 ade6 
Y.J. Xu Lab 
YJ1230 h+ erg11(G189D):ura4+ cds1-6his2HA [prom-
erg11-term-LEU2] leu1-32 ura4-D18 ade6 
Y.J. Xu Lab 
 
 
 
TABLE 3. List of PCR and sequencing primers used in the study 
 
Name Sequence (5’ -> 3’) Note 
Hem13(P)SacI-f AAAGGAGCTCTATTAGTTTATAACA
AAAG 
Colony PCR 
Hem13(T)SphI-b GTACGCATGCTAACGTTTTATGACTT
G 
Gene cloning & 
Colony PCR 
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Hem13(P)SacI-f TAGAGAGCTCATAGTAAAATACTTA
ACCATATG 
Gene cloning 
Hem13(444-463)f CTTTGAAGAAGATGGCAAGC Sequencing 
Hem13(592-575)b GAAAATACCGCCAATGCCAC Sequencing 
Hem13(239-222)b    TTTGGACAGCGTCTTGATTC Sequencing 
Hem13(780-799)f    CAGAGGTACTTGGTTTGGTC Sequencing 
Hem13PSphI-f ACCCGCATGCGATCGCGCTATTC Tagging 
Hem13 NotI-b GTGAGCGGCCGCAGCACCATTCAA
TAGGGG 
Tagging 
S.C.Hem13NdeI-f CATACATATGCCTGCCCCTCAAG Gene cloning 
S.C.Hem13SmaI-b GAACCCCGGGTTATTTAACCCACTC Gene cloning 
H.S.Hem13NdeI-f CGGGCATATGGCCTTGCAGCTG Gene cloning 
H.S.Hem13SmaI-b TCTGCCCGGGTCAACGCACCCAGTC Gene cloning 
Ura4(term)f TTATAGATAAACACCTTGGG Colony PCR 
Ura4-b2 CTACCAATTCTAAGATTTCGGATTT
C 
Colony PCR 
 
TABLE 4. List of plasmids used in the study 
Name Description Source 
pYJ1588 Prom-suc22+/LEU2 Y.J. Xu Lab 
pAPS47 Prom-∆hem13 (ura4+)-term/ura4+ This study 
pAPS49 Prom-hem13+/ura4+ This study 
pAPS50 Prom-hem13 (T263I)/ura4+ This study 
pAPS51 Prom-hem13+-3HA/LEU2 This study 
pAPS52 Prom-hem13-3HA (T263I)/LEU2 This study 
pAPS53 Prom-hem13+/LEU2 This study 
pAPS54 Prom-hem13 (T263I)/LEU2 This study 
pAPS88 pREP1-S.C. hem13+-nmt term/LEU2 This study 
pAPS89 pREP41-S.C. hem13+-nmt term/LEU2 This study 
pAPS90 pREP1-H.S. hem13+-nmt term/LEU2 This study 
pAPS91 pREP41-H.S. hem13+-nmt term/LEU2 This study 
pYJ1519 Prom-erg11+/LEU2 Y.J. Xu Lab 
pAPS66 pJK148-Prom-hem13+ This study 
pAPS67 pJK148-Prom-hem13 (T263I) This study 
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RESULTS 
Identification of a novel hem13 mutant that is highly sensitive to HU in S. pombe 
A novel HU sensitive mutant of coproporphyrinogen III oxidase in the heme biosynthesis 
pathway 
In order to better understand the activation mechanism of Rad3 in S. pombe, we designed 
a genetic screening using low dose HU (2 mM). At this dose of HU, only the sensor 
mutants of the checkpoint pathway (rad3∆, rad26∆, rad17∆, rad9∆, rad1∆ and hus1∆) 
are sensitive, the mediator (mrc1∆), the effector (cds1∆), and the downstream factor 
mutants survive (Fig. 2). We identified several mutants using low dose HU. To gate out 
the known checkpoint mutants, we cloned all the genes in the checkpoint pathway on a S. 
pombe expression vector. All vectors were stoichiometrically mixed as the defined 
checkpoint library. The HU sensitive mutants that were identified using the above 
mentioned genetic screening were transformed with the checkpoint library. The library 
will rescue mutation in known checkpoint genes. With this strategy, we could quickly 
gate out the mutations in known checkpoint genes and were able to identify several novel 
mutants whose HU sensitivity was comparable to the checkpoint sensor mutants. Further 
characterization of one of the novel mutant led to the identification of a new HU sensitive 
mutant in the heme biosynthesis pathway (Fig. 4) with a mutation in hem13+ encoding 
for the enzyme coproporphyrinogen III oxidase (101). In S. pombe, genome wide deletion 
study identified hem13+ as an essential gene for cell growth (102). We confirmed this
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finding and showed that hem13+ is essential for cell survival (Fig. 6). 
Coproporphyrinogen III oxidase is an oxygen requiring enzyme whose transcription is 
regulated by cellular levels of oxygen and heme (103). It catalyzes the aerobic oxidative 
decarboxylation of propionate groups of rings A and B of coproporphyrinogen-III to 
yield the vinyl groups in protoporphyrinogen-IX (Fig. 4B) (104). Characterization of the 
mutant identified a single nucleotide change resulting in T263I mutation in the catalytic 
center of the enzyme. The HU sensitivity of hem13 mutant is remarkable in that it is even 
higher than rad3∆ strain (Fig. 7A). The hem13 mutation was also associated with cold 
sensitivity (Fig. 7B), whereby the mutant cells were unable to survive on plates incubated 
at 22˚C, consistent with the essential function of the enzyme. 
The homologous enzyme of Hem13 in humans is called coproporphyrinogen oxidase 
(CPOX) (105). Defects in heme synthesis in humans leads to hepatic or erythropoietic 
porphyrias. Acute hepatic porphyria, also called hereditary coproporphyria, is 
characterized by acute attacks of neurological dysfunction (106-108). Skin 
photosensitivity has also been predicted for the patients. Defects in erythropoietic cells 
leads to harderoporphyria, which is characterized by neonatal hemolytic anemia and skin 
lesions (109,110). The mutated amino acid threonine 263 in the hem13+ gene is believed 
to be one of the catalytic residues in human homolog CPOX (104,111,112). Mutation of 
the same residue to asparagine in humans reduced the enzymatic activity by 69% (105).  
 
Confirmation of the mutation in hem13+ gene 
The T263I mutation in hem13+ gene was confirmed in S. pombe. Wild type and mutant 
genes were cloned on a S. pombe expression vector. The plasmid containing the wild type
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Figure 4: Schematic depicting heme biosynthetis pathway 
A. The highly conserved enzymatic pathway starts with condensation of succinyl-CoA 
and glycine and ends up with the formation of heme b, which is the major heme 
molecule. While heme synthesis occurs partially in mitochondria, several intermediary 
steps occur in cytoplasm. The hem13+ gene encodes the enzyme coproporphyrinogen 
oxidase (shown in bold), involved in catalyzing the sixth step of the heme synthesis 
pathway. 
 
B. The enzyme catalyzes the aerobic oxidative decarboxylation of propionate groups of 
rings A and B of coproporphyrinogen-III to yield vinyl groups in protoporphyrinogen-IX. 
Short lines in the figure represent the propionate groups of rings A and B of 
coproporphyrinogen III and vinyl groups of protoporphyrinogen IX.
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Figure 5: Disruption of hem13+ gene by integrating ura4+  
The 934 bp open reading frame (ORF) of hem13+ and two flanking genes byr4+ and 
SPAC222.17 are shown by long arrows. The hem13+ gene was cloned into the pIRT-2U 
vector between SacI and SphI sites using PCR primers hem13(P)SacI-f and 
hem13(T)SphI-b (short arrows). The 139 bp region of the hem13+ ORF (196 bp to 335 bp 
from the start codon) between the NcoI (blunt end generated) and HincII sites was 
replaced with ura4+ marker cut with BamHI (blunt end generated) and SmaI. The 
resulting construct was digested with BglII and BspEI to isolate the 3885 bp fragment 
containing the hem13+ destructed cassette by agarose gel electrophoresis. The purified 
fragment was transformed into the wild type diploid strain YJ18. Colonies formed on 
plates lacking uracil were screened by colony PCRs to confirm the 5’ and 3’ integration 
using the indicated primer pairs generating 1300 bp and 2137 bp expected PCR products.
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Figure 6: Hem13 is essential for cell survival in S. pombe 
A. The hem13+ gene was disrupted in diploid cells by integrating ura4+ gene into its 
ORF. ura+ diploid colonies were selected and allowed to sporulate on plates with poor 
medium. Tetrad dissection was performed to separate the spores. Out of colonies formed 
from four spores, ≤ 2 colonies could survive suggesting that hem13+ is essential for cell 
survival.  
B. All the colonies formed above were ura- as the colonies failed to grow on ura- plates, 
confirming that hem13+ gene is essential for cell survival.
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Figure 7: The newly screened hem13 mutant is highly sensitive to HU 
A. Spot assay showing HU sensitivity of hem13 mutant. Wild type and rad3 mutant 
strains were used as controls. 
B. Cold sensitivity associated with the hem13 mutation. The mutant cells were unable to 
grow on plates incubated at 22˚C as compared to wild type cells.
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Figure 8: Confirmation of hem13 mutation  
A. Wild type or mutant Hem13 was expressed from plasmids under the control of its own 
promoters in the hem13 mutant. Spot assay was done to monitor the HU and cold 
sensitivity. 
B. Wild type or mutant Hem13 was expressed in the hem13+/hem13∆ diploid strain from 
plasmids. The diploid strain was allowed to sporulate to generate hem13∆ haploid cells 
containing the plasmids. Spot assay was performed later. 
C. The hem13 mutation was integrated at the hem13+ genomic locus in a wild type strain. 
Wild type hem13+ was integrated by the same method. Standard spot assay was done to 
show the HU and cold sensitivity of the integrated strains.
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Fig 9: Integration of Hem13 (T263I) mutation at the genomic locus 
The Hem13 (T263I) mutation was integrated at the genomic locus using the hem13+ 
/∆hem13::ura4+diploid strain. The wild type and mutant hem13 gene were cloned on 
pIRT-2U vector. Both plasmids containing wild type and mutant gene were cut with 
BspEI and BglII. The resulting 1551 bp fragment was purified by agarose gel 
electrophoresis. The purified fragment was transformed into ∆hem13::ura4+ diploid 
strain. The cells were allowed to recover on YE6S plates for 24 h and replica plated on 5-
fluoroorotic acid (5-FOA) plates to select for ura- colonies. The resulting diploid ura- 
colonies were allowed to sporulate on plates with poor medium. Random spore analysis 
was performed to separate the spores.  
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Figure 10: Partial rescue of hem13 mutant by S. cerevisiae and human orthologs 
A. Pairwise sequence alignment of amino acid sequences of Hem13 protein in S. pombe, 
S. cerevisae and human orthologs. Threonine 263, the mutated residue in hem13 mutant 
is highly conserved from yeasts to humans. 
B. Hem13 from budding yeast and CPOX from humans were expressed from S. pombe 
expression vector under the control of nmt (no mRNA in the presence of thiamine) 
promoter. The nmt1 and nmt41 indicates strong and weak promoters, respectively.
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gene could suppress the HU sensitivity of the mutant cells whereas the mutant version of 
the gene failed to rescue, suggesting that the hem13 gene is mutated (Fig. 8A). The wild 
type gene was also able to suppress the cold sensitivity of the mutant whereas the mutant 
gene could not (Fig. 8A). Next we transformed the hem13+/hem13∆ diploid strain with 
vectors expressing wild type and mutant hem13. Later the diploid colonies were allowed 
to sporulate and haploid colonies with hem13∆ containing the plasmids were selected. 
Plasmid carrying hem13+ gene could suppress both the HU and cold sensitivity in the 
hem13∆ background in haploid cells whereas the mutant version of the gene expressed on 
plasmid could not suppress the HU and the cold sensitivity (Fig. 8B). Finally the 
mutation was integrated at the hem13+ genomic locus (Fig. 9) and HU and cold 
sensitivity was confirmed (Fig. 8C). 
 
C. Partial rescue of hem13 mutant by S. cerevisiae and human orthologs 
Pairwise sequence alignment showed that mutated threonine 263 residue in Hem13 is 
conserved among fission yeast, budding yeast and humans (Fig. 10A), and the mutated 
residue is believed to be at the active site in human enzyme (104,111,112). It has been 
reported that mutation of this residue to asparagine reduces the enzymatic activity of 
CPOX by 69% (105). We cloned S. cerevisiae and human genes on S. pombe expression 
vector and over-expressed in our hem13 mutant (Fig. 10B). Consistent with the conserved 
function of the enzyme, the over-expressed S. cerevisiae and human orthologs can partly 
rescue hem13 mutant. This result also suggests the possibility of decreased enzymatic 
activity of hem13 mutant. It also suggests that a similar cell killing mechanism of HU 
may be conserved from yeasts to humans.
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Checkpoint independent role of HU in sensitizing hem13 cells 
Acute treatment of hem13 mutant with HU suggests a different cell killing kinetics in 
hem13 mutant compared to the rad3∆ checkpoint mutant 
The hem13 mutant is remarkably sensitive to chronic exposure of HU (Fig. 7). However 
when we assessed the sensitivity of the hem13 mutant to acute HU treatment using 
previously described method (95), we found hem13 mutant to be relatively insensitive 
(Fig. 11). HU treatment of wild type cells slowed their growth but the cells were able to 
survive indicating a reversible cell cycle arrest. On the contrary, by 3 h of HU treatment, 
most of rad3∆ cells could not recover. However, the hem13 mutant was minimally 
sensitive to acute HU treatment and was able to survive even after 6 h of HU treatment. 
This result suggests that HU-induced cell death in hem13 mutant is caused by a different 
mechanism. 
 
Overexpression of Suc22 in hem13 mutant did not rescue its HU sensitivity 
Another evidence that led us to suspect that a defect in checkpoint pathway may not be 
the underlying cause of cell death in hem13 mutant came from the fact that when we 
overexpressed Suc22 in hem13 mutant, we found that the HU sensitivity of the hem13 
mutant could not be suppressed, in contrast to that in checkpoint mutants rad3∆ and 
cds1∆ cells (Fig. 12). Suc22 is the small subunit of RNR and the major target of activated 
replication checkpoint. As a result, overexpression of Suc22 can fully rescue the mutants 
in the checkpoint signaling pathway. Thus this result also shows that cell death induced
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 Figure 11:  The hem13 mutant is minimally sensitive to acute treatment of HU 
Wild type, rad3∆ and hem13 cells were incubated in YE6S medium containing 25 mM 
HU. At each time point, 10 µl of cells were diluted in 10 ml sterile dH2O, extensively 
vortexed, and 100 µl or about 200 cells were then spread onto YE6S plates. The plates 
were incubated at 30°C for 3 days for the cells to recover. Colonies resulting from the 
recovered cells were counted and presented as percentages of the untreated cells. Each 
data point represents an average of colonies from three plates.
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Figure 12: Overexpression of Suc22 in hem13 mutant did not rescue its HU 
sensitivity 
Unlike the rad3∆, cds1∆ checkpoint mutant cells, overexpression of the small subunit of 
RNR Suc22 was unable to rescue hem13 mutant. Suc22 was expressed under the control 
of its own promoter on a vector carrying the LEU2 marker. An empty vector was used as 
a control. Spot assay was done to monitor HU sensitivity.
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by HU in the newly identified hem13 mutant is not due to dNTP depletion or DNA 
damage generated by fork collapsing (113,114). 
 
Resistance of hem13 mutant to DNA damaging agents 
Next we monitored the sensitivity of hem13 mutant to DNA damaging agents MMS, CPT 
and UV. We found that hem13 mutant is minimally sensitive to the DNA damaging 
agents. In contrast, the checkpoint mutant rad3∆ is sensitive to these DNA damaging 
agents under similar conditions (Fig. 13). Consistent with this result, we observed an 
increase in Chk1 phosphorylation in hem13 mutant after treatment with MMS suggesting 
that checkpoint signaling from Rad3 to Chk1 remained largely intact in hem13 mutant 
after the cells were treated with MMS (Fig. 14A). The rad3∆ strain was used as negative 
control in this experiment since Rad3 phosphorylates Chk1. Previous studies have shown 
that Chk1 is also activated in HU treated cells lacking a functional replication checkpoint; 
probably by DNA damage resulting from the collapsed forks (32). As a result, Chk1 is 
highly phosphorylated in cds1∆ cells. If forks are collapsed in HU-treated hem13 mutant 
cells, Chk1 should be phosphorylated. However, we found that Chk1 was minimally 
phosphorylated in the presence of HU, suggesting that fork collapse occurs at a low level 
in the hem13 mutant cells (Fig. 14B). 
 
Phosphorylation of Cds1 in hem13 mutant cells  
Cds1 is the major mediator of the replication checkpoint in S. pombe. Its activation 
involves a two-stage mechanism (33,38,115): In the first stage, Cds1 is recruited by 
phosphorylated Mrc1 for its phosphorylation by Rad3 at the Thr11 residue. In the second
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Figure 13: The hem13 mutant cells are minimally sensitive to DNA damage caused 
by MMS, CPT or UV 
The sensitivity of wild type, rad3∆, cds1∆, chk1∆ and hem13 cells to MMS (A), CPT (B) 
and UV (C) was determined by spot assay.
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Figure 14: Chk1-mediated DNA damage response is not affected in hem13 mutant 
Wild type, rad3∆, cds1∆ and hem13 cells were treated with (+) or without (-) 0.01 % 
MMS (A) for 80 minutes or with 25 mM HU (B) for 4 h at 30˚C. The phosphorylation of 
Chk1 by Rad3 was determined by standard mobility shift assay as described in Materials 
and Methods.
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stage, phosphorylated Cds1 promotes homodimerization of two inactive Cds1 molecules, 
which facilitates the autophosphorylation of Thr328 in the activation loop of the kinase 
domain. Autophosphorylation of Thr328, which is suppressed by the autoinhibitory C- 
terminal tail, directly activates the Cds1 kinase. Because phosphorylation of Cds1-Thr11 
by Rad3 primes the autoactivation of the kinase, it has been used as a reliable marker for 
Cds1 activation (115,116). As shown in Fig. 15, phosphorylation of Cds1-Thr11 was 
significantly increased in wild type cells after 3 h of HU treatment. However, we found a 
dramatic reduction of Cds1 phosphorylation in hem13 mutant. This result showed that the 
Rad3-mediated signaling in the replication checkpoint pathway was seriously 
compromised in hem13 mutant, suggesting a defect in checkpoint pathway activation in 
hem13 mutant, which is inconsistent with our results mentioned above that the cell death 
is caused by checkpoint independent defect.  
To understand why Cds1 phosphorylation was affected in hem13 mutant, we analyzed the 
cell cycle progression of hem13 mutant. In the presence of HU, most of wild type cells 
arrested in G1/S phase after 4 h of HU treatment. We found that hem13 mutant has a cell 
cycle defect that might indirectly affect the Cds1 phosphorylation. While most of the wild 
type cells arrested in G1/S phase after 4 h of HU treatment (Fig. 16), the hem13 cells 
were unable to be arrested in G1/S phase by HU treatment. Surprisingly, most of the 
hem13 cells remained in G2/M during the HU treatment suggesting a G2/M arrest (Fig. 
16). Since Cds1 is specifically activated in S phase, a defect in cell cycle could be an 
underlying cause of a defect in Cds1 activation. To investigate this possibility, we 
crossed hem13 mutant with cdc10-129 temperature sensitive strain, selected for the 
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Figure 15: Reduced Cds1 phosphorylation in hem13 mutant cells 
Cds1 was tagged with HA epitope at the C-terminus and expressed at the cds1+ genomic 
locus in wild type cells or the hem13 mutant. After the cells were treated with HU, 
phosphorylation of Cds1-Thr11 was assessed in IPed Cds1 by Western blotting using 
phospho-specific antibody (top panel). Loading of Cds1 was examined by blotting the 
same membrane with anti-HA antibody (lower panel).
	
	 60	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	
	 61	
Figure 16: HU causes G2/M, not S phase arrest in hem13 mutant 
The HU induced cell cycle arrest in wild type cells (left column) and in hem13 mutant 
(right column) was analyzed by flow cytometry. The logarithmically growing 
asynchronized cells were marked as “Asyn” on the bottom. Dashed lines indicate the 2C 
DNA content.
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Figure 17: Forced entry of hem13 cells in S phase in the presence of HU restores 
Cds1 phosphorylation 
A. Logarithmically growing HA tagged Cds1 cdc10-129 (WT) cells or the HA tagged 
Cds1 Cdc10-129 hem13 cells were arrested in G1 phase by incubating at the non-
permissive temperature (36.5˚C) for 4 h. The G1 arrested cells were then released into the 
cell cycle by incubating at the semi-permissive temperature (30˚C) in the presence or 
absence of HU (25 mM). Every hour during the release, an equal number of cells were 
taken out from the culture to monitor Cds1 phosphorylation. Phosphorylation of Cds1-
Thr11 was assessed in IPed Cds1 by Western blotting using phospho-specific antibody 
(top panel). Loading of Cds1 was examined by blotting the same membrane with anti-HA 
antibody (lower panel).   
B. The cells were also fixed at the indicated time points during the course of the 
experiment for cell cycle analysis. The logarithmically growing asynchronized cells 
before the G1 arrest were marked as “Asyn” on the bottom. Dashed lines indicate the 2C 
DNA content.
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double mutant, and arrested the hem13 cdc10-129 double mutant cells at G1 phase of the 
cell cycle by incubating at 36.5˚C and then released the cells at 30˚C (used 30˚C instead 
of 25˚ C because of cold sensitivity of hem13 cells) in medium containing HU. During 
the course of this block and release, Cds1 phosphorylation was monitored. We found that 
Cds1 was fully phosphorylated in hem13 cells just like in the wild type cells under the 
similar conditions (Fig. 17). Although, Cds1 was phosphorylated an hour before in 
hem13 cells compared to wild type cells after release in HU, we believe that this is due to 
cell cycle defect of hem13, leading to less stringent synchronization at G1 and 
subsequently earlier release. 
 
Reduced Mrc1 Phosphorylation levels in hem13 mutant 
When DNA replication is perturbed by HU, Rad3 phosphorylates two TQ motifs in Mrc1 
containing Thr645 and Thr653. Once phosphorylated, the two TQ motifs function 
redundantly in recruiting Cds1 for its phosphorylation by Rad3 (38). As shown in Fig. 18, 
when wild type cells were treated with HU, Mrc1-Thr645, which is used as the 
representative of the two redundant TQ motifs, was highly phosphorylated and the 
phosphorylation absolutely required Rad3. We found reduced Mrc1 phosphorylation in 
hem13 mutant cells, suggesting a checkpoint defect. However, the Mrc1 levels were 
lower in hem13 mutant compared to that in wild type cells. We believe that the lower 
Mrc1 level is a result of cell cycle defect in hem13 cells, similar to the scenario leading to 
reduced Cds1 phosphorylation in hem13 mutant cells because Mrc1 is specifically 
expressed during S phase. 
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Figure 18: Reduced Mrc1 phosphorylation in hem13 mutant cells 
Wild type cells, cells lacking Mrc1 or Rad3 and hem13 mutant cells were incubated in 
YE6S medium with (+) or without (-) HU (25mM) at 30˚C for 3 h. The cells were 
collected for preparing the whole cell extracts as described in Materials and Methods. 
After separation on SDS-PAGE, phosphorylation of Mrc1-Thr645 by Rad3 was examined 
by Western blotting using the phospho-specific antibody (upper panel). Asterisk denotes 
a cross-reactive material. The membrane was stripped and reprobed with the polyclonal 
antibodies against Mrc1 (middle panel). A section of Ponceau S-stained membrane is 
shown as loading control (bottom panel).
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Genetic interaction of hem13 mutant with checkpoint mutants  
To see whether hem13 genetically interacts with the checkpoint mutants, we crossed the 
hem13 mutation into rad3∆, chk1∆ and cds1∆ strains and tested the sensitivity of the 
resulting double mutants to HU. We found that the double mutants were more sensitive to 
HU than the single checkpoint mutant (Fig. 19). However the HU sensitivity of the 
double mutants are similar to hem13 mutant suggesting that the hem13 mutation is 
dominant. 
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Figure 19: The hem13 mutant functions in a separate pathway with the checkpoint 
mutants 
The HU sensitivity of wild type, hem13 and the cells with the indicated single or double 
mutations was determined by spot assay.
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Oxidative stress as an underlying cause of HU-induced cell death in hem13 mutant 
Our data described above suggests that cell killing effect of HU in hem13 mutant is 
independent of the checkpoint defect. Studies in other organisms (117-120) suggest that 
in addition to DNA damage generated by collapsed forks, HU may kill the cells by 
generating oxidative stress. SMP, an inhibitor of heme synthesis (121), has been shown to 
induce apoptosis in a human leukemia cell line by generation of reactive oxygen species 
(ROS) (122). We surmise that the cell death induced by HU in the newly identified 
hem13 mutant could be due to increased ROS, not dNTP depletion (113,114). 
 
Oxygen dependent HU and cold sensitivity of hem13 mutant 
To test the hypothesis that HU-induced cell death in hem13 mutant is due to increased 
ROS, we examined the HU sensitivity under anaerobic conditions since mitochondria are 
the major intracellular source of ROS. We reasoned that if collapsed forks directly kill 
the cells, the cell death should be observed in both checkpoint mutants and hem13 mutant 
and the cell death should be independent of the two growth conditions. We observed that 
while the checkpoint mutants remained sensitive to HU under anaerobic environment, the 
sensitivity of hem13 mutant was fully suppressed under the similar conditions, suggesting 
that HU sensitivity of hem13 is dependent on oxygen and that the cell death under 
aerobic conditions may be due to increased ROS (Fig. 20A). Considering slower cell 
growth rate and drug decomposition under anaerobic conditions, higher dose of HU was 
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Figure 20: Oxygen dependent HU and cold sensitivity of hem13 mutant 
A. Wild type, rad3∆, cds1∆, sre1∆ and hem13 were spotted on control and 5.0 mM HU 
plates and incubated for 3 days at 30˚C under aerobic and anaerobic conditions. Sre1∆ 
mutant was used as the control for anaerobic conditions. 
B. Wild type, rad3∆, cds1∆, sre1∆ and hem13 cells were spotted and incubated at 30˚C 
and 22˚C under aerobic and anaerobic conditions for 3 days to monitor for the cold 
sensitivity of hem13 mutant.
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used. It was found that the hem13 mutant cells were resistant to higher doses of HU under 
oxygen restrictive environment. Sre1 is a sterol regulatory element binding protein, a 
transcription factor required for cellular response to hypoxia (123). The sre1∆ mutant 
was used as a positive control for anaerobic conditions because in the absence of Sre1, 
the cells cannot survive under anaerobic conditions. We also monitored the cold 
sensitivity of the hem13 mutant under oxygen restrictive environment and found that cold 
sensitivity of hem13 can also be suppressed by depleting oxygen (Fig. 20B) because 
heme is not required for cell growth under anaerobic conditions (124). 
  
Sensitivity of hem13 mutant to other oxidants 
The data described above suggest that HU may generate oxidative stress leading to cell 
death in hem13 mutant cells. We then tested whether hem13 mutant is sensitive to 
oxidants such as hydrogen peroxide (H2O2). We found that wild type and rad3∆ cells 
were able to survive on plates containing 3 mM of H2O2, but not on plates containing 5 
mM H2O2. However, hem13 mutant cells were sensitive to 3 mM H2O2, strengthening our 
idea that oxidative stress is the underlying cause of cell death in HU-treated hem13 
mutant cells (Fig. 21). Ptc4 is the protein phosphatase 2c required for activating the stress 
induced MAP kinase Sty1 and is required during cellular response to H2O2 (125). The 
ptc4∆ cells have been shown to be sensitive to H2O2 (125) and were used as positive 
control in this experiment. As shown in Fig. 21, hem13 is even more sensitive to H2O2 
than the ptc4∆ mutant under similar conditions.
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Figure 21: The hem13 mutant is hypersensitive to oxidative stress generated by 
H2O2  
Wild type, rad3∆, hem13 and ptc4∆ cells were spotted on control plates and plates 
carrying varying concentration of H2O2 and incubated for 3 days at 30˚C. Ptc4 mutant is 
required during cellular response to H2O2 and was used as a positive control for oxidative 
stress.
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Next, we monitored hem13 cells survival on plates containing glycerol as the carbon 
source instead of glucose. Yeast cells mainly undergo fermentation when glucose is 
present in the medium to generate ethanol and carbon dioxide (126). Glycerol is a non- 
fermentable source of carbon. In the presence of glycerol, respiratory enzymes are 
required to generate energy (126). Cells with increased oxidative stress will generate 
more ROS in the presence of glycerol as the carbon source. The wild type and the 
checkpoint mutant cells with intact enzymatic and nonenzymatic defenses required to 
cope with oxidative stress were able to grow in the presence of the glycerol as the carbon 
source. The ptc4∆ cells with a defect in oxidative stress response (125) were found to be 
sensitive on plates containing glycerol and were used as the positive control. Under 
similar conditions, the hem13 mutant cells were also found to be sensitive on plates 
containing glycerol suggesting that hem13 mutant is sensitive to oxidative stress (Fig. 
22). This sensitivity can be suppressed by adding glucose to the plates.  
 
The HU sensitivity of hem13 can be suppressed by antioxidant N-acetylcysteine  
We then examined the HU sensitivity of hem13 in the presence of the antioxidant N-
acetylcysteine. An earlier study has shown that mutant cells with increased oxidative 
stress survive better in the presence of antioxidant cysteine (126). We hypothesized that 
the presence of antioxidant on the plates will prevent the oxidation of macromolecules 
inside the cells, thereby helping the cells to survive better on HU plates. We observed 
that the HU sensitivity of hem13 cells was suppressed by the antioxidant even at 5 mM 
concentration (Fig. 23). cds1∆ cells survived slightly better at 3 mM HU concentration in 
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Figure 22: The hem13 mutant sensitivity on plates containing glycerol as carbon 
source  
Wild type, rad3∆, hem13 and ptc4∆ cells were spotted on control plates and plates 
carrying glucose, glycerol and glucose + glycerol as carbon source. The plates were 
incubated for 3 days at 30˚C. The ptc4∆ strain was used as positive control because it is 
sensitive to oxidative stress (125).
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Figure 23: Anti-oxidant can suppress the HU sensitivity of hem13 cells 
The sensitivity of wild type, rad3∆, cds1∆ and hem13 cells to HU and HU + anti-oxidant 
N-acetyl cysteine was determined by spot assay. After spotting the cells on plates, the 
plates were incubated at 30˚C for 3 days.
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the presence of the antioxidant, probably because inappropriate entry into mitosis in 
checkpoint mutants has been shown to generate ROS inside the cells (127). However at 5 
mM HU, the cds1∆ cells did not show increased survival in the presence of the 
antioxidant. The antioxidant did not show any effect on the HU sensitivity of rad3∆ 
mutant. 
 
Increased production of ROS inside the hem13 mutant cells as measured by DCFDA 
staining 
The results described above strongly suggest that HU treatment generates oxidative stress 
in hem13 mutant. However, direct evidence remains lacking. We used the cell membrane 
permeable DCFDA dye to detect the generation of ROS (128). Thus it can detect ROS in 
both living and dead cells. We used PI (129) to distinguish between dead and live cells; 
since PI cannot pass through the intact membranes of living cells. Because fission yeast 
cells display auto fluorescence even in the absence of dye, we measured the extent of 
staining in the absence as well as the presence of dyes. We found that while the untreated 
wild type cells show very insufficient fluorescence signal, the HU treated wild type cells 
have slightly higher fluorescence signal in the presence of HU. The untreated hem13 cells 
had slightly higher signal whereas the HU treated hem13 cells showed a significant 
increase in the fluorescence signal suggesting increased ROS (Fig. 24). Although, in the 
absence of dye, the hem13 cells alone showed a shift in the signal. This signal is different 
than the fluorescent signal obtained from the DCFDA. Thus an increase in DCFDA 
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 Figure 24:  Increased DCFDA fluorescence signal inside the HU treated hem13 cells 
A. Wild type and hem13 cells treated with or without HU were incubated in the presence 
of DCFDA for 80 minutes at 30˚C. The cells were then harvested, washed and 
resuspended in buffer containing PI. The results are displayed as scatter plots with 
increasing ROS displayed on horizontal axis and increasing PI signal displayed on the 
vertical axis. In each case 10,000 cells were scanned. To count the DCFDA positively 
stained cells, the gaits were set as shown in the figure. The gait boundaries were set up to 
include the cells in the stained populations having fluorescence signals higher than those 
in the unstained populations. The percentage of cells appearing in each of the gated 
regions is also displayed. 
B. The same results were displayed in histogram form with increasing amounts of ROS 
on the horizontal axis.
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fluorescence signal inside hem13 cells as a result of HU treatment suggests increased 
oxidative stress generation with HU treatment. 
 
Increased protein carbonylation inside the hem13 mutant as a result of HU 
treatment 
We provided another evidence of increased oxidative stress inside hem13 cells treated 
with HU by measuring protein carbonyaltion levels. Protein carbonylation is an 
irreversible protein damage caused by oxidative stress which leads to the loss of protein 
function (130). This type of protein damage has been considered as a reliable indicator of 
oxidative damage (130). The side chains of lysine, arginine, proline, threonine and other 
amino acid residues can be oxidized to ketones and aldehydes under oxidative stress. 
These reactive ketones and aldehydes can react with DNPH to form hydrazone moieties 
that can be detected using antibodies against DNPH derivatized proteins by western 
blotting (98,99). We measured protein carbonylation in hem13 mutant cells treated with 
or without HU and found that the protein carbonylation levels were significantly higher 
in the HU-treated hem13 mutant cells indicating that HU increases oxidative stress inside 
the hem13 cells (Fig. 25). The untreated hem13 mutant cells have slightly higher level of 
protein carbonylation suggesting oxidative stress under normal growth conditions, 
compared to untreated wild type and rad3∆ cells. This experiment provided one more 
piece of direct evidence that there is significantly increased oxidative stress inside hem13 
cells after HU treatment. The wild type and rad3∆ cells have minimal levels of protein 
carbonylation, which further decreased slightly with HU treatment suggesting that 
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activation of oxidative stress regulon remains intact inside these S. pombe cells similar to 
the scenario in S. cerevisiae (120).
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Figure 25: Increased protein carbonylation inside hem13 mutant cells 
Wild type, rad3∆ and hem13 cells were treated with 25 mM HU for 4 h. Same number of 
cells were collected, suspended in protein carbonylation buffer and lysed. Cell extracts 
were reacted with DNPH, followed by SDS-PAGE and western blot analysis by using α-
DNP antibody. A section of the Ponceau S stained membrane and western blotting using 
anti-PKG antibody were used as the loading controls.
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Heme deficiency predisposes cells to HU-induced oxidative stress 
Reduced heme levels inside hem13 mutant  
Since the Thr263 residue mutated in Hem13 has been proposed to be the active site residue 
of the human CPOX and mutation of this residue to asparagine in humans reduces the 
enzymatic activity by 69% (105), we surmised that the mutation causes heme deficiency 
in hem13 mutant. To test this possibility, the heme levels inside the hem13 cells were 
measured using the heme measuring kit (Bio Vision, CA). We measured the heme levels 
inside the wild type and hem13 cells untreated or treated with 25 mM HU or 0.004 mM 
SMP and found that heme levels were lower in hem13 cells compared to the wild type 
cells (Fig. 26). HU treatment slightly reduced the heme levels inside the wild type cells 
and hem13 mutant, possibly because of the requirement of heme for generating more 
ergosterol inside the cell (discussed below), whereas SMP treatment dramatically reduced 
the heme levels inside the cells as expected. We used 0.004 mM of SMP because at this 
concentration, wild type cells were minimally sensitive to SMP. hem13 mutant cells did 
not show any marked difference in heme levels with SMP treatment probably because 
heme was already at the lowest level inside the mutant cells. Thus this experiment 
provides direct evidence that heme level is low in hem13 mutant cells. 
 
Exogenously supplied hemin can suppress HU and cold sensitivity of hem13 mutant
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Figure 26: Reduced heme levels inside the hem13 mutant cells 
Wild type and hem13 cells treated with 25 mM HU or 0.004 mM SMP were lyzed. Cell 
extracts were used to measure the heme levels using heme measuring kit. The protein 
concentration of each cell lysate was also measured and used to calculate heme 
concentration as fmol/µg protein. Bar: Standard deviation. *: Statistically significant with 
p-values < 0.05.
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Figure 27: Exogenously supplied hemin can suppress both HU and cold sensitivity 
of hem13 mutant cells 
A. Wild type, rad3∆ and hem13 mutant cells untreated (-) and treated (+) with 50 µg/ml 
of hemin for three days were spotted on control, HU, hemin (50 µg/ml) and HU + hemin 
plates and incubated further for 3 days at 30˚C. 
B. Similar to A, cells were cultured with 50 µg/ml of hemin for three days and were 
spotted on control and hemin (50 µg/ml) plates and incubated at 22˚C for 3 days to 
monitor for cold sensitivity.
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Since heme level was low inside the hem13 mutant, we wanted to test if exogenously 
supplied hemin can suppress the HU and cold sensitivity. We treated the wild type, rad3∆ 
and hem13 cells with exogenous hemin for three days and then spotted the cells on HU 
and HU + hemin plates. We found that the exogenously supplied hemin can suppress 
both HU and cold sensitivity of hem13 mutant cells (Fig. 27 A, B). Even at 5 mM HU 
concentrations, the cells were able to survive just like the wild type cells. In contrast, the 
exogenously supplied hemin could not suppress the HU sensitivity of rad3∆ strain. This 
result suggests that reduced heme inside the hem13 cells is the underlying cause of both 
HU and cold sensitivity of hem13 cells.  
 
Increased Hem13 protein levels inside the hem13 mutant cells  
An earlier study showed that Hem13 is an oxygen-requiring enzyme and is negatively 
regulated by heme and oxygen levels inside the cells (103). We monitored the Hem13 
levels inside the hem13 cells and found that there was an increase in Hem13 protein level 
compared to the wild type cells (Fig. 28), consistent with the notion of reduced heme 
levels inside the hem13 mutant cells. However, HU treatment did not further increase the 
Hem13 protein levels inside the wild type and hem13 cells. Thus the increased Hem13 
levels inside the hem13 mutant are consistent with reduced heme levels inside the hem13 
cells in the presence or absence of HU. 
 
Exogenously supplied hemin can alleviate the cell cycle defect of hem13 mutant 
Cell cycle analysis by flow cytometry showed a cell cycle defect in hem13 mutant (Fig. 
16), in which the mutant cells arrested in G2/M phase, not G1/S by HU. Since 
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Figure 28: Increased Hem13 protein levels inside the hem13 cells 
Untagged, HA-tagged Hem13 expressed in wild type and hem13 mutant cells were 
treated with or without HU and the cells were collected and lysed. Whole cell extracts 
were prepared, run on SDS page gels, transferred on to the nitrocellulose membrane and 
probed with anti-HA antibody (Top panel). A section of the Ponceau S stained membrane 
is shown as the loading control (bottom panel).
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Figure 29: Cell cycle defect of hem13 can be suppressed by exogenously supplied 
hemin 
Hem13 cells were incubated with (left panel) or without (right panel) 50 µg/ml hemin for 
three days. The cells were then treated with 25 mM HU. The cells were fixed at the 
indicated time points during the course of the experiment for cell cycle analysis by flow 
cytometer. Dashed lines indicate the 2C DNA content. Asynchronized cells at the bottom 
represent the cells at the start of the HU treatment.
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exogenous hemin can suppress HU sensitivity, we tested if exogenously supplied hemin 
can also correct the cell cycle defect. We found that in the presence of exogenously 
supplied hemin, nearly half of the cells arrested in G1/S phase, in contrast to the 
untreated cells, which remained in G2/M phase in the presence of HU (Fig. 29). 
 
Excess of free iron inside the cells- an underlying cause of HU sensitivity 
The results described above showed that the mutation in Hem13 causes the deficiency of 
heme. However, why the heme deficiency sensitizes the cells to HU remains unknown. In 
yeasts, majority of the iron taken by the cells is utilized for the synthesis of heme and 
assembly of the iron-sulfur clusters, which occurs in the mitochondria (131). The 
deficiency of heme inside the hem13 cells may lead to excess labile iron inside the 
mutant cells. Since free iron can promote the formation of free radicals inside the cells 
(132), it is possible that excess free iron might be involved in generating oxidative stress 
inside the cells and causes the HU sensitivity. To test this idea we used the membrane 
permeable, intracellular Fe2+ chelator, 2,2’-bipryidine (BP) which has been shown 
previously to quench the labile iron pool within the eukaryotic cells (133-135).  We 
hypothesized that chelating this labile iron pool, which may otherwise promote 
generation of free hydroxyl radicals inside the cells, will help the hem13 cells to survive 
better. We found that wild type cells showed slight suppression of cell growth when both 
HU and BP were present in the plates. The situation is worst for cds1∆ checkpoint mutant 
because adding HU and BP together completely suppresses its growth, probably by 
quenching the iron required for RNR recycling (26). However, the hem13 mutant cells 
survive better on HU plates in the presence of BP, suggesting that an excess of free iron 
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could be one of the underlying causes of HU sensitivity in hem13 mutant cells (Fig. 
30A). 
 
Overexpression of Hem15 suppresses HU sensitivity of hem13 cells 
hem15+ in S. pombe encodes for ferrochelatase. In S. cerevisiae, ferrochelatase is an inner 
mitochondrial membrane protein (136) that catalyzes the last step of the heme 
biosynthetic pathway (Fig. 4A) by inserting ferrous iron into protoporphyrin IX (137). 
We found that overexpression of Hem15 in hem13 mutant partially suppresses its HU 
sensitivity possibly by binding of free labile iron (Fig. 30B). Alternatively, more end 
product heme is synthesized in the cells.  
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Figure 30: Quenching free iron inside the cells suppresses HU sensitivity of the 
hem13 mutant 
A. Wild type, rad3∆, cds1∆ and hem13 cells were spotted on control plates, HU and HU 
+ bipyridyl plates. The plates were incubated further for 3 days at 30˚C. 
B. Hem15 was overexpressed under the control of its own promoter on a S. pombe 
expression vector. An empty vector was used as control. Serial dilutions of wild type and 
hem13 mutant carrying empty vector and hem15+ were spotted on control and HU plates. 
The plates were incubated further for 3 days at 30˚C.
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Partial rescue of HU sensitivity of hem13 mutant by overexpression of Erg11 
Since overexpression of the small subunit of RNR Suc22 could not suppress the HU 
sensitivity of hem13 mutant cells, suggesting that in addition to RNR, there may be a 
secondary target of HU. Identification of such a target(s) can be of great biological and 
clinical significance. To look for the potential new target of HU, we screened for multiple 
copy suppressors of hem13 mutant. To this end, we transformed the hem13 mutant with 
the genomic DNA libraries established in our lab that carry the ura4+ marker. Colonies 
grown on plates lacking uracil were replicated on plates containing HU to screen for 
those that are endowed with HU resistance. Plasmids were recovered from HU resistant 
yeast colonies for DNA sequencing and subsequent identification of the suppressor 
genes. Interestingly, we found that erg11+ could suppress the HU sensitivity of the 
hem13 mutant (Fig. 31). In S. cerevisiae, erg11+ encodes for lanosterol 14-demethylase, a 
member of cytochrome P-450 family, in the biosynthesis of ergosterol, a sterol similar to 
mammalian cholesterol that is specifically found in fungal membranes (138). Data from 
budding yeast suggests that Dap1, a heme binding protein, activates Erg11, thereby 
elevating the metabolism of lipids and xenobiotic compounds and provides resistance to 
DNA alkylating agent methyl methanesulfonate (MMS) (139). It is possible that proper 
functioning of Erg11 is affected in hem13 mutant due to heme deficiency and decreased 
ergosterol synthesis may also cause the HU sensitivity. Consistent with this notion, a 
newly identified erg11 mutant in our lab is highly sensitive to HU (Fig. 31). We further 
tested the hem13 mutant sensitivity to ergosterol inhibitor terbinafine and found that 
hem13 mutant is more sensitive to this agent suggesting that ergosterol synthesis may be 
affected in hem13 mutant (Fig. 32).
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Figure 31: Overexpression of Erg11 can partially suppress the HU sensitivity of 
hem13 mutant 
Erg11 was expressed in wild type, rad3∆, erg11 and hem13 mutant under the control of 
its own promoter. Serial dilutions of above mentioned cells were spotted on control plates 
and plates containing different concentrations of HU. The plates were incubated further 
for 3 days at 30˚C. One of the plates was incubated at 22˚C for 3 days to monitor for cold 
sensitivity.  Cells transformed with empty vectors were used as controls.
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Figure 32: The hem13 mutant is more sensitive to ergosterol inhibitor terbinafine 
Wild type, rad3∆, cds1∆, chk1∆, erg11 and hem13 cells were spotted on control plates 
and plates containing different concentrations of terbinafine. Unlike the checkpoint 
mutants that have similar sensitivity as the wild type cells, the hem13 mutant was more 
sensitive to terbinafine.
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Synergistic effect of HU and SMP in suppressing fungal cell growth  
The hem13 mutant is highly sensitive to an inhibitor of heme synthesis, SMP.  
Since HU sensitivity of hem13 mutant is attributed to low heme levels inside the cells; we 
hypothesized that hem13 mutant with a defect in heme synthesis would be more sensitive 
to SMP and WT, rad3∆ and cds1∆ cells with intact heme synthesis pathway will be 
relatively resistant to SMP. We found that the wild type and checkpoint mutant cells 
rad3∆, cds1∆, were much less sensitive to SMP, in contrast to hem13 mutant that is 
highly sensitive to SMP (Fig. 33).  
 
Synergistic effect of HU and SMP in suppressing the cell growth of S. pombe 
Since the hem13 mutant is sensitive to the inhibitor of heme synthesis, SMP, we reasoned 
that inhibition of the heme synthesis pathway in wild type S. pombe might mimic the 
mutant phenotype and thus sensitize the cells to HU. To test this idea we performed a 
spot assay on plates containing SMP, HU or both and monitored the drug effects on cell 
growth. We used low concentration of HU (1.5, 3 mM) and SMP (0.004 mM). At these 
concentrations of HU and SMP, wild type cells were able to survive on the plates. 
However when these two drugs were combined together, there was a marked suppression 
in cell growth suggesting a synergistic effect of the drugs on cell growth in wild type 
cells (Fig. 34). 
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Figure 33: The hem13 mutant is highly sensitive to an inhibitor of heme synthesis, 
SMP 
Wild type, rad3∆, cds1∆ and hem13 cells were spotted on control plates and plates 
containing different concentration of SMP. 
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Figure 34: Increased sensitivity of wild type S. pombe cells to HU in the presence of 
SMP 
Wild type, rad3∆, cds1∆ and hem13 cells were spotted on control, HU, SMP and HU + 
SMP plates. 
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Figure 35: Cell killing effect of HU and SMP on wild type S. pombe  
Logarithmically growing wild type S. pombe cells were inoculated on 96 well plates at 
3000 cells/well. Various concentrations of HU (A) or SMP (B) were added to the final 
volume of 200 µl to each well. The same amounts of carriers were added as control. Cells 
were incubated at 30˚C for 48 h. The plates were scanned in a plate reader at A600. The 
graphs were made from values obtained from the plate reader using Microsoft Excel.
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Figure 36: Combination of HU and SMP shows synergistic cell killing effect on wild 
type S. pombe 
A. CI values of the various drug combinations using non-constant combo ratios. Values 
marked in bold indicate strong synergistic effects. 
B. Graphical representation of the cell killing effect of HU, SMP and various 
combinations of the two drugs. The numbers indicate the various combinations. 
C. Combination index plot. Fa values on the x-axis are the values of cell survival at 
various CI values.
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Figure 37: Time course analysis of a HU + SMP combo showing strong synergism in 
wild type S. pombe 
Logarithmically growing S. pombe cells were inoculated on 96 well plates at 3000 
cells/well. The HU (10mM), SMP (0.021 mM) and their combo showing strong 
synergistic effects were chosen for the time course analysis. The same amounts of 
carriers were added as control. Cells were incubated at 30˚C and the plates were scanned 
in a plate reader at A600 at the indicated time points. The graphs were then made from 
values obtained from the plate reader using Microsoft Excel. Each data points are the 
average of three readings.
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To analyze this synergistic drug effect in detail, we measured the drug effects in 96 well 
plates as described in Material and Methods. The dose response of each drug was 
obtained in order to determine the concentration required to suppress 50% cell growth  
(IC 50 value) (Fig. 35). The drug concentrations showing minimal effects on cell growth 
were then chosen for the drug combinations. The synergistic, additive and antagonistic  
effects between the combined drugs were determined by using Chou and Talalay method 
(96). As shown in Fig. 36, most of the combinations of SMP and HU showed synergistic 
effect as the calculated combination index (CI) values are less than 1.0 (see Table 1 in 
Materials and Methods for detail) (97). Although a few combinations showed the additive 
(CI values ≈ 1.0) or antagonistic (CI values > 1.0) effect, more than half of the 
combinations showed a very strong synergism (CI values < 0.1) (Fig. 36, numbers in 
bold). These data are consistent with the spot assay results from Fig. 34 and support the 
result that the lower level of heme is the underlying cause of the hem13 mutant HU 
sensitivity. We also monitored the cell killing effect by time course analysis of a HU + 
SMP combo that showed strong synergism over the course of long term drug treatment 
and found that after 16 h of HU and SMP treatment alone, the cells were able to recover 
from the individual drugs whereas they failed to recover from the two drugs combined. 
 
Synergistic effect of HU and SMP in suppressing the cell growth of S. cerevisiae 
We also assessed the effect of SMP and HU on S. cerevisiae, another nonpathogenic 
fungus that is phylogenetically distinct from S. pombe. The dose response of individual 
drug was obtained to determine IC 50 value (Fig. 38). Similar synergistic effects were 
observed in S. cerevisiae as described for S. pombe (Fig. 39). 
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Synergistic effect of HU and SMP in suppressing the cell growth of C. albicans 
We then tested the effect of HU and SMP on the pathogenic fungus C. albicans (Fig. 42). 
Most of the combinations showed a strong synergistic effect. Similar to S. cerevisiae, 
higher concentrations of HU are required to achieve the dramatic cell killing effect on C. 
albicans as it is known that both fungi are more resistant to HU (Fig. 38A, 41A). 
	
	
	
	 121	
Figure 38: Cell killing effect of HU and SMP on wild type S. cerevisiae 
Logarithmically growing S. cerevisiae cells were inoculated on 96 well plates at 3000 
cells/well. Various concentrations of drug alone were then added to the final volume of 
200 µl to each well. The same amounts of carriers were added as control. Cells were 
incubated at 30˚C for 48 hrs. The plates were scanned in a plate reader at A600. The 
graphs were then made using excel from values obtained from the plate reader.
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Figure 39: Combination of HU and SMP shows synergistic cell killing effect on wild 
type S. cerevisiae 
A. CI values of the various drug combinations using non-constant combo ratios. Values 
marked in bold indicate strong synergistic effects. 
B. Graphical representation of the cell killing effect of HU, SMP and various 
combinations of the two drugs. The numbers indicate the various combinations. 
C. Combination index plot. Fa values on the x-axis are the values of cell survival at 
various CI values. 
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Figure 40: Time course analysis of a HU + SMP combo showing strong synergism in 
wild type S. cerevisiae 
Logarithmically growing S. cerevisiae cells were inoculated on 96 well plates at 3000 
cells/well. The HU (250 mM), SMP (0.035 mM) and their combo showing strong  
synergistic effects were chosen for the time course analysis. The same amounts of  
carriers were added as control. Cells were incubated at 30˚C and the plates were scanned  
in a plate reader at A600 at the indicated time points. The graphs were then made using  
excel from values obtained from plate reader. Each data points are the averages of three 
readings.
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Figure 41: Cell killing effect of HU and SMP on pathogenic fungus C. albicans 
Logarithmically growing C. albicans cells were inoculated on 96 well plates at 3000 
cells/well. Various concentrations of SMP were then added to the final volume of  
200 µl to each well. The same amounts of carriers were added as control. Cells were  
incubated at 30˚C for 48 hrs. The plates were scanned in a plate reader at A600. The  
graphs were then made using excel from values obtained from the plate reader.
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Figure 42: Combination of HU and SMP shows synergistic cell killing effect on 
pathogenic fungus C. albicans 
A. CI values of the various drug combinations using non-constant combo ratios. Values 
marked in bold indicate strong synergistic effects. 
B. Graphical representation of the cell killing effect of HU, SMP and various 
combinations of the two drugs. The numbers indicate the various combinations. 
C. Combination index plot. Fa values on the x-axis are the values of cell survival at 
various CI values. 
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Figure 43: Time course analysis of a HU + SMP combo showing strong synergism in 
pathogenic fungus C. albicans  
Logarithmically growing C. albicans cells were inoculated on 96 well plates at 3000 
cells/well. The HU (200 mM), SMP (0.086 mM) and their combo showing strong  
synergistic effects were chosen for the time course analysis. The same amounts of  
carriers were added as control. Cells were incubated at 30˚C and the plates were scanned  
in a plate reader at A600 at the indicated time points. The graphs were then made using  
excel from values obtained from the plate reader.
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DISCUSSION 
 
Aerobically respiring organisms generate ROS, such as superoxide radicals, hydroxyl 
radicals, hydrogen peroxide, which can damage various macromolecular components 
inside the cells such as nucleic acids, proteins and lipids (140). One of the major sources 
of oxidative stress in the aerobically respiring organisms is the mitochondrial electron 
transport chain (ETC) (74). Cells have developed sophisticated mechanisms to deal with 
ROS generated by aerobic respiration. These include enzymatic and nonenzymatic 
defenses to maintain a reducing environment inside the cells. Glutathione, glutaredoxins, 
thioredoxins and NADPH constitute the nonenzymatic defenses employed by the cells to 
detoxify ROS (74). Superoxide dismutases, catalases and peroxidases constitute the 
enzymatic defenses of the cells to detoxify ROS (141). 
Recently, numerous studies suggest that HU, a RNR inhibitor (25) may generate 
oxidative stress inside both prokaryotic (117) and eukaryotic cells (118,120) which 
eventually lead to cell death. One of these studies suggests that HU sensitivity may not be 
mediated through dNTP regulatory network (118). It is also known that HU can directly 
kill cells by DNA damage resulting from collapsed forks as a result of dNTP depletion 
inside the cells (113,114). These two cell killing mechanisms overlap since inappropriate 
entry into mitosis in checkpoint mutant cells can generate ROS (76). A mutant that can 
separate these two cell killing mechanisms of HU can be valuable. Our characterization 
of the hem13 mutant provides several lines of evidences that HU generates oxidative 
stress, not checkpoint defect leading to cell death (113,114). 
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I provided the following evidence that cell death in hem13 mutant is independent of a 
checkpoint defect. First, the failure of overexpressed Suc22 to rescue the HU sensitivity 
of hem13 mutant (Fig.12) suggests that the defect is not mediated by dNTP regulatory 
network. Second, the acute treatment of hem13 with HU shows a different kinetics of cell 
death compared to the checkpoint mutant rad3∆ (Fig. 11). Third, resistance of hem13 
mutant to other DNA damaging agents such as MMS, CPT and UV (Fig. 13) and an 
intact Rad3 to Chk1 signaling (Fig. 14A) and minimal phosphorylation of Chk1 with HU 
treatment (Fig. 14B) further supports the idea that cell death is not mediated by DNA 
damage caused by collapsed forks. Although the dramatic reduction in Cds1 
phosphorylation (Fig. 15) was inconsistent with our idea of checkpoint independent cell 
death mechanism in hem13 mutant, it was found that defect in Cds1 phosphorylation was 
a result of cell cycle defect in hem13 cells (Fig. 16) and Cds1 phosphorylation could be 
fully restored in hem13 mutant cells by forcing the cells into G1 phase and then release in 
S phase in the presence of HU (Fig. 17).  
Next I provided evidence suggesting oxidative stress as an underlying cause of cell death. 
First the HU sensitivity of hem13 mutant is dependent on oxygen (Fig. 20). I also found 
that hem13 mutant is sensitive to other oxidants such as H2O2 (Fig. 21). Second, the HU 
sensitivity of hem13 mutant could be suppressed by the presence of antioxidant N-acetyl 
cysteine (Fig. 23), suggesting a strong correlation between oxidative stress and cell death. 
Third, increased ROS staining by DCFDA (Fig. 24) and increased protein carbonylation 
(Fig. 25) in HU-treated hem13 cells provided direct evidence of increased oxidative stress 
in hem13 mutant as a result of HU treatment. Thus, my work unveils a novel cell killing 
mechanism of HU in S. pombe. 
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The key question is how this oxidative stress is generated inside the hem13 cells as a 
result of HU treatment. My data suggest that hem13 mutant has reduced heme levels 
inside the cells and this conclusion is supported by, first, heme measurements using a 
commercially availaible kit showed that heme level is significantly lower in hem13 
mutant cells (Fig. 26). Second, exogenously supplied hemin could suppress the HU and 
cold sensitivity of hem13 mutant (Fig. 27) and also alleviate the cell cycle defect of 
hem13 mutant (Fig. 29). Third, increased Hem13 protein levels inside the hem13 mutant 
(Fig. 28) cells also suggest decreased levels of heme. Since exogenous hemin can fully 
suppress the HU sensitivity, I believe that the heme deficiency predisposes the cells to 
oxidative stress induced by HU in hem13 mutant. However the exact mechanism remains 
unclear, which is discussed below. 
The low heme levels inside the mutant cells may lead to an excess of free labile iron 
inside the cells since most of the iron taken up by yeast is utilized for the synthesis of 
heme and assembly of iron-sulfur clusters in the mitochondria (131). My hypothesis of 
excess free iron inside the cells as a result of heme depletion is supported by the fact that 
patients with mutation in CPOX, which is one of the underlying causes of human 
coproporphyrias, have severe iron load (105). Some of the patients with mutation in 
CPOX have very high serum ferritin levels (109). Since free iron is a powerful promoter 
of free-radical damage, causing formation of hydroxyl radicals inside the cells (132), it is 
possible that the increased free iron inside the hem13 cells causes oxidative stress. This 
was indeed true as quenching the free iron inside the mutant cells with the membrane 
permeant, intracellular Fe2+ chelator, 2,2’-bipyridine was able to suppress the HU 
sensitivity of hem13 mutant (Fig. 30A). Overexpression of Hem15 encoding 
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ferrochelatase, which binds iron inside the cells, also partially suppressed HU sensitivity 
of hem13 mutant (Fig. 30B). Thus, my data suggests that there is excess free labile iron 
inside the cells that may be one of the underlying causes of HU sensitivity of hem13 
mutant. Alternatively, since heme is also required for respiratory enzymes, heme 
deficiency may perturb their function leading to increased oxidative stress. 
How excess free iron and HU treatment of the cells lead to oxidative stress? It has been 
suggested that HU inhibition of RNR could result in the formation of the hydroperoxy 
form of the HU, which can diffuse away from RNR and act as an oxidizing agent (26). 
The oxidized form of HU generates more oxidative stress in hem13 mutant compared to 
the wild type cells, possibly by reacting with the increased free iron inside the mutant 
cells. Since excess free iron is not available in wild type cells, the cells can survive better 
with HU, even though HU still generates minimal oxidative stress in wild type cells as 
shown by Yap1 activation with HU treatment (120). However, the exact mechanism by 
which HU generates oxidative stress remains unclear.  
Based on all the data I presented in this thesis, I propose a model, which depicts the two 
different HU induced cell killing mechanisms in S. pombe (Fig. 44). 
I also found that overexpression of Erg11 can suppress the HU sensitivity of hem13 
mutant (Fig. 31). This is not surprising since heme is required for the enzymatic activities 
of Erg3, Erg5 and Erg11, highlighting the possible importance of heme for ergosterol 
synthesis (138,142). It has been reported that to protect the cells from oxidative stress, 
there is strong response from gene products of the ergosterol synthesis pathway (143). 
Thus, reduction in heme levels possibly affects the enzymatic activity for the ergosterol 
synthesis, required for protecting the cells against oxidative stress. Since ergosterol is a 
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sterol similar to cholesterol in humans, it is possible that cholesterol may similarly 
provide the resistance to cancer cells against HU. 
Apart from hem13 mutant leading to the discovery of novel cell killing mechanism of HU 
in S. pombe, my newly identified mutant in the heme biosynthesis pathway led to the 
discovery of synergistic effects of the two drugs, HU and SMP, which has great 
implications in improving the antifungal therapy. Since my data suggest that hem13 
mutant has an underlying deficiency of heme, which leads to its HU sensitivity, I 
mimicked this result by inhibition of the heme biosynthesis pathway using SMP and 
found that SMP has a synergistic effect with HU in suppressing cell growth in wild type 
S. pombe, S. cerevisiae and the pathogenic fungus C. albicans. The CI values (< 0.1) of 
various combinations of HU and SMP as determined by Chou and Talalay method 
(96,97) suggest strong synergism of the two drugs in all fungi tested. So far, because S. 
pombe, S. cerevisiae and C. albicans are phylogenetically distinct, this result suggests 
that combination of HU and SMP may suppress cell growth of other pathogenic fungi as 
well. Fungal diseases are a global public health problem. About 1.2 billion people 
worldwide are estimated to suffer from fungal diseases (144). Most are infections of the 
skin, nails or mucosa, but a substantial minority, particularly in individuals who have 
weakened immune systems, such as the patients who have cancer or HIV/AIDS, is 
invasive or chronic and difficult to treat. It is estimated that 1.5 to 2 million people die of 
a fungal infection each year. Most of this mortality is caused by species belonging to four 
genera of fungi: Aspergillus, Candida, Cryptococcus and Pneumocystis. Although 
effective antifungals such as second generation azoles (ergosterol biosynthesis 
inhibitors), echinocandins (cell wall synthesis inhibitor) and amphotericin B (membrane 
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Fig 44: Model depicting HU induced cell killing mechanisms in wild type and hem13 
mutant in S. pombe 
HU, by inhibitng RNR depletes dNTP levels inside the cells, activates the checkpoint 
pathway. Under stress conditions induced by HU, the checkpoint responses are absolutely 
required for cell survival. Abrogation of the pathway leads to collapsed forks, and DNA 
damage leading to cell death. On the other hand, in the presence of heme deficiency and 
excess iron inside the cells, HU treatment generates oxidative stress by an unknown 
mechanism. The increased oxidative stress, if not properly handled by the cells, leads to 
modification of proteins and other macromolecules and eventually cell death.
	
	 139	
 
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	 140	
pore formation) are available, the toxicity of these drugs and the increasing threat of drug 
resistance hamper the effective treatment of fungal infections. Combination therapy using 
multiple drugs may tackle these issues associated with the single drug therapy. To this 
end, the strong synergistic effect of SMP and HU holds a great potential for the 
combination therapy to treat fungal infections. Interestingly, SMP is being tested as one 
of the drugs in antifungal pipeline (144). We plan to extend our finding to other known 
species of pathogenic fungi such as Aspergillus fumigatus, Histoplasma capsulatum and 
Cryptococcus neoformans in search for more effective therapies against fungal diseases. 
Because HU has already been used in cancer chemotherapy (1) and SMP can inhibit 
heme synthesis in humans (121) and has been shown to kill a human leukemia cell line 
by generating ROS (122), our combination therapy using HU and SMP may also have the 
potential to be used to treat cancers.  
In summary, my work defines that oxidative stress is an underlying cause of HU 
sensitivity of hem13 mutant in S. pombe and reveals the strong synergistic effect of HU 
and SMP in suppressing cell growth of wild type S. pombe, S. cerevisiae and the 
pathogenic fungus C. albicans.
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Abbreviations 
 
atg (Autophagy Related genes) 
ATM (Ataxia Telangiectasia Mutated) 
ATR (ATM -and Rad3-related) 
CDK (cyclin dependent kinase) 
CI (Combination Index) 
 CPOX (Coproporphyrinogen Oxidase) 
CPT (Camptothecin) 
DDR (DNA damage response) 
DMSO (Dimethyl sulfoxide) 
DNA (deoxyribose nucleic acid) 
DNPH (2 4-dinitrophenyl hydrazine) 
dNTPs (deoxyribonucleoside triphosphates) 
ER (Endoplasmic Reticulum) 
ESR (environmental stress response) 
FADD (Fas-associated death domain) 
H2O2 (Hydrogen peroxide) 
HA (hemagglutinin) 
 HU (hydroxyurea) 
IP (immunoprecipitation) 
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mM (millimolar) 
 MMS (Methylmethane Sulfonate) 
Mrc1 (mediator of Replication Checkpoint) 
nmt (no mRNA in the presence of thiamine) 
OD (Optical Density) 
 ORC (Origin Recognition Complex) 
ORF (open reading frame) 
PAGE (Polyacrylalmide Gel Electrophoresis) 
PCNA (Proliferating Cell Nuclear Antigen) 
PI (Propidium Iodide) 
PI3K (phosphatidylinositol-3-OH Kinase) 
Pkg (Protein Kinase G) 
 PMSF (Phenylmethylsulfonyl Flouride) 
pre-IC (pre-initiation complex) 
pre-RC (pre-replication complex) 
RNR (Ribonucleotide Reducatse) 
ROS (Reactive Oxygen Species) 
RPA (Replication Protien A) 
SDS (Sodium Dodecyl Sulfate) 
SMP (Sampangine) 
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